TR201804452A2 - OZONEED OIL CONTAINING SOLUTIONS - Google Patents
OZONEED OIL CONTAINING SOLUTIONS Download PDFInfo
- Publication number
- TR201804452A2 TR201804452A2 TR2018/04452A TR201804452A TR201804452A2 TR 201804452 A2 TR201804452 A2 TR 201804452A2 TR 2018/04452 A TR2018/04452 A TR 2018/04452A TR 201804452 A TR201804452 A TR 201804452A TR 201804452 A2 TR201804452 A2 TR 201804452A2
- Authority
- TR
- Turkey
- Prior art keywords
- oil
- nano
- ozonized
- solutions
- ozone
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 239000003921 oil Substances 0.000 claims description 436
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 164
- 238000000034 method Methods 0.000 claims description 99
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 58
- 238000006385 ozonation reaction Methods 0.000 claims description 56
- 239000002245 particle Substances 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 35
- 239000003995 emulsifying agent Substances 0.000 claims description 31
- 239000012153 distilled water Substances 0.000 claims description 20
- 238000005507 spraying Methods 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229940068968 polysorbate 80 Drugs 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- 238000005194 fractionation Methods 0.000 claims description 4
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 229940068977 polysorbate 20 Drugs 0.000 claims description 4
- 210000002969 egg yolk Anatomy 0.000 claims description 3
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 235000013345 egg yolk Nutrition 0.000 claims description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- -1 Iisophospholipid Substances 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000019198 oils Nutrition 0.000 description 402
- 239000000243 solution Substances 0.000 description 267
- 238000011282 treatment Methods 0.000 description 86
- 239000007924 injection Substances 0.000 description 68
- 238000002347 injection Methods 0.000 description 68
- WURFKUQACINBSI-UHFFFAOYSA-M ozonide Chemical compound [O]O[O-] WURFKUQACINBSI-UHFFFAOYSA-M 0.000 description 68
- 210000001519 tissue Anatomy 0.000 description 42
- 230000000694 effects Effects 0.000 description 40
- 208000015181 infectious disease Diseases 0.000 description 40
- 230000008569 process Effects 0.000 description 24
- 208000027418 Wounds and injury Diseases 0.000 description 22
- 206010052428 Wound Diseases 0.000 description 21
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 20
- 239000001301 oxygen Substances 0.000 description 20
- 229910052760 oxygen Inorganic materials 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 239000003814 drug Substances 0.000 description 19
- 241000196324 Embryophyta Species 0.000 description 18
- 239000007789 gas Substances 0.000 description 18
- 239000008158 vegetable oil Substances 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 230000036541 health Effects 0.000 description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 description 17
- 229940079593 drug Drugs 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 15
- 239000003925 fat Substances 0.000 description 15
- 235000012055 fruits and vegetables Nutrition 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 230000003110 anti-inflammatory effect Effects 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- 238000002560 therapeutic procedure Methods 0.000 description 13
- 241000287828 Gallus gallus Species 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 235000013330 chicken meat Nutrition 0.000 description 12
- 238000000694 mesotherapy Methods 0.000 description 12
- 238000006213 oxygenation reaction Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 239000000829 suppository Substances 0.000 description 11
- 235000013311 vegetables Nutrition 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 239000003589 local anesthetic agent Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 241000233866 Fungi Species 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000645 desinfectant Substances 0.000 description 9
- 229940088710 antibiotic agent Drugs 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000012188 paraffin wax Substances 0.000 description 8
- 206010000269 abscess Diseases 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 7
- 239000003549 soybean oil Substances 0.000 description 7
- 235000012424 soybean oil Nutrition 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- 210000002249 digestive system Anatomy 0.000 description 6
- 208000030533 eye disease Diseases 0.000 description 6
- 238000007918 intramuscular administration Methods 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 206010033675 panniculitis Diseases 0.000 description 6
- 238000007920 subcutaneous administration Methods 0.000 description 6
- 210000004304 subcutaneous tissue Anatomy 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 5
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- 206010019909 Hernia Diseases 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 208000002925 dental caries Diseases 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 208000014617 hemorrhoid Diseases 0.000 description 5
- 238000000265 homogenisation Methods 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 208000000509 infertility Diseases 0.000 description 5
- 230000036512 infertility Effects 0.000 description 5
- 231100000535 infertility Toxicity 0.000 description 5
- 239000007937 lozenge Substances 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 235000019168 vitamin K Nutrition 0.000 description 5
- 239000011712 vitamin K Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010016717 Fistula Diseases 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 4
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 4
- 229930003448 Vitamin K Natural products 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000001363 autoimmune Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 239000012459 cleaning agent Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 229960005015 local anesthetics Drugs 0.000 description 4
- 239000007923 nasal drop Substances 0.000 description 4
- 229940100662 nasal drops Drugs 0.000 description 4
- 235000019645 odor Nutrition 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 description 4
- 229940046010 vitamin k Drugs 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 3
- 206010017533 Fungal infection Diseases 0.000 description 3
- 241000590002 Helicobacter pylori Species 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 206010039085 Rhinitis allergic Diseases 0.000 description 3
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 3
- 235000019486 Sunflower oil Nutrition 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 201000010105 allergic rhinitis Diseases 0.000 description 3
- 230000001760 anti-analgesic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 201000003146 cystitis Diseases 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 239000003221 ear drop Substances 0.000 description 3
- 229940047652 ear drops Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000008029 eradication Effects 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 239000003889 eye drop Substances 0.000 description 3
- 229940012356 eye drops Drugs 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 210000002850 nasal mucosa Anatomy 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000002600 sunflower oil Substances 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 230000000451 tissue damage Effects 0.000 description 3
- 231100000827 tissue damage Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 208000001860 Eye Infections Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010022678 Intestinal infections Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000010332 Plantar Fasciitis Diseases 0.000 description 2
- 208000004550 Postoperative Pain Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000000491 Tendinopathy Diseases 0.000 description 2
- 206010043255 Tendonitis Diseases 0.000 description 2
- 206010044016 Tooth abscess Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 208000021328 arterial occlusion Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960003150 bupivacaine Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002894 chemical waste Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 206010009887 colitis Diseases 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 238000004851 dishwashing Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000011323 eye infectious disease Diseases 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001146 hypoxic effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000022760 infectious otitis media Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000001361 intraarterial administration Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 2
- 229940073769 methyl oleate Drugs 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000007922 nasal spray Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000009329 organic farming Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 235000021485 packed food Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000003182 parenteral nutrition solution Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000020989 red meat Nutrition 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 201000004415 tendinitis Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000287 tissue oxygenation Effects 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- MAYCICSNZYXLHB-UHFFFAOYSA-N tricaproin Chemical compound CCCCCC(=O)OCC(OC(=O)CCCCC)COC(=O)CCCCC MAYCICSNZYXLHB-UHFFFAOYSA-N 0.000 description 2
- 229940093609 tricaprylin Drugs 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- 208000000143 urethritis Diseases 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 235000020990 white meat Nutrition 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001889 Alveolitis Diseases 0.000 description 1
- 206010048946 Anal abscess Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000501711 Centaurium Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010024995 Lumbar hernia Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000055008 Matrilin Proteins Human genes 0.000 description 1
- 108010072582 Matrilin Proteins Proteins 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 208000014151 Stomatognathic disease Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 208000004760 Tenosynovitis Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000010516 ayurvedic herbal oil Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000003515 dental abscess Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000000883 ear external Anatomy 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000028299 esophageal disease Diseases 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000002767 hepatic artery Anatomy 0.000 description 1
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 201000009019 intestinal benign neoplasm Diseases 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000011418 maintenance treatment Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 206010033072 otitis externa Diseases 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010734 process oil Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229940100618 rectal suppository Drugs 0.000 description 1
- 239000006215 rectal suppository Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011521 systemic chemotherapy Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 206010051250 ureteritis Diseases 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 208000010484 vulvovaginitis Diseases 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/02—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by the production or working-up
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B4/00—General methods for preserving meat, sausages, fish or fish products
- A23B4/10—Coating with a protective layer; Compositions or apparatus therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/144—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of gases, e.g. fumigation; Compositions or apparatus therefor
- A23B7/152—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere comprising other gases in addition to CO2, N2, O2 or H2O ; Elimination of such other gases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/16—Coating with a protective layer; Compositions or apparatus therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/003—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/01—Other fatty acid esters, e.g. phosphatides
- A23D7/011—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/90—Feeding-stuffs specially adapted for particular animals for insects, e.g. bees or silkworms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/54—Mixing with gases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3409—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor
- A23L3/3445—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere comprising other gases in addition to CO2, N2, O2 or H2O
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3481—Organic compounds containing oxygen
- A23L3/3508—Organic compounds containing oxygen containing carboxyl groups
- A23L3/3517—Carboxylic acid esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/358—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05F—ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE
- C05F11/00—Other organic fertilisers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/006—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by oxidation
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
- C11D17/0017—Multi-phase liquid compositions
- C11D17/0021—Aqueous microemulsions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Dermatology (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pest Control & Pesticides (AREA)
- Biophysics (AREA)
- Insects & Arthropods (AREA)
- Ophthalmology & Optometry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Otolaryngology (AREA)
Abstract
Buluşta, nano veya mikron boyutlarda ozonlanmış yağ içeren solüsyonlar, bu solüsyonların üretim metotları ve kullanım alanları açıklanmaktadır.The invention discloses solutions containing nano- or micron-sized ozonated oil, their production methods and uses.
Description
TARIFNAME OZONLANMIS YAG IÇEREN SOLUSYONLAR Teknik Alan Bulus, ozonlanmis yag içeren solüsyonlar, bu solüsyonlarin üretim metotlari ve kullanim alanlari ile ilgilidir. DESCRIPTION SOLUTIONS CONTAINING OZONED OIL Technical Area The invention includes solutions containing ozonized oil, production methods of these solutions and related to usage areas.
Bulus özellikle, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar, bu solüsyonlarin üretim metotlari ve kullanim alanlari ile ilgilidir. In particular, solutions containing ozonized oil in nano or micron sizes It is related to the production methods and usage areas of the solutions.
Teknigin Bilinen Durumu Oksijenin allotropu olan ozon (03) üç oksijen atomundan olusan bir bilesiktir. Ozon, oksitleme gücü yüksek, renksiz ve keskin kokulu bir gazdir. Ozonun kullanim alani incelendiginde çok çesitli kullanim alanlari ile karsilasilmaktadir. Ozon, suda ve havada koku giderici ve dezenfektan olarak kullanilmaktadir. Oksitleme gücü yüksek oldugu için ortami kirleten organik molekül ve mikroorganizmalari yok etmektedir. Böylece gida sektöründe dezenfektan olarak ve gidalarin uzun süre depolanmalarinda da kullanilmaktadir. Diger kullanim alanlari ise tipta enfeksiyonlarda, dolasim bozukluklarinda, eklem hastaliklarinda, bagirsak hastaliklarinda, cilt hastaliklarinda vb. hastaliklarda, veterinerlikte hayvan sagligini korumak ve hastaliklarda tedavi amaçli, kozmetik sektöründe cilt ve saç ürünlerinde ve tekstilde agartici olmak üzere birçok alanda kullanilmaktadir. Ozon dogada günesin ultraviyole isinlari veya yildirimlar vasitasiyla meydana gelmektedir. Mevcut teknikte ozon çesitli üretim teknolojileriyle üretilebilmektedir. Bunun için genel olarak ozon jeneratörleri kullanilmaktadir. State of the Art Ozone (03), the allotrope of oxygen, is a compound consisting of three oxygen atoms. Ozone, It is a colorless and pungent odor gas with high oxidizing power. Usage area of ozone When examined, it is encountered with a wide variety of usage areas. Ozone in water and air It is used as an odor remover and disinfectant. It has high oxidizing power It destroys organic molecules and microorganisms that pollute the environment. so food It is also used as a disinfectant in the industry and for long-term storage of foods. is used. Other areas of use are infections of the type, circulation. disorders, joint diseases, intestinal diseases, skin diseases, etc. in diseases, to protect animal health in veterinary medicine and to treat diseases, in the cosmetics industry, in skin and hair products, and in textiles as bleach. used in the field. Ozone is caused by ultraviolet rays of the sun or lightning in nature. occurs through. In the current technique, ozone is used with various production technologies. can be produced. For this purpose, ozone generators are generally used.
Ozonun saglik alaninda kullanilmasi ozon terapi olarak adlandirilmaktadir. Mevcut teknikte yer alan baslica ozon terapi yöntemleri: majör otohemoterapi, minör otohemoterapi, ozonla zenginlestirilmis su, ozon/oksijen gaz karisiminin dogrudan enjeksiyon seklinde eklem ve dokulara uygulanmasi, rektal ve vajinal uygulamalar, eksternal terapi ve ozonla zenginlestirilmis yag uygulamalaridir. The use of ozone in the field of health is called ozone therapy. Available the main ozone therapy methods in the technique: major autohemotherapy, minor autohemotherapy, ozone-enriched water, direct injection of ozone/oxygen gas mixture injection into joints and tissues, rectal and vaginal applications, external therapy and ozone-enriched oil applications.
Ozon aktif bir molekül oldugu için kisa sürede etkisini yitirmekte ve oksijene dönüsmektedir. Ozon, depolanamamasi ve 20“C'de 40 dakikalik yari ömre sahip olmasi nedeniyle bir seferde kullanilmasi gereken stabil olmayan bir gazdir. Bu yüzden genellikle üretildigi yerde ve seri bir sekilde kullanilmaktadir. Ayrica, ozon terapinin uzman kisilerce yapilmasi ve uygulama için hastane veya klinik gibi ortamlar gerektiginden kullanim alanlari dar ve maliyetleri oldukça fazladir. Ayni zamanda ozon terapi yöntemlerinin pratik olmamasi ve kisinin her zaman her yerde istedigi ari uygulayamamasi bu yöntemlerin dezavantajlarindan biridir. Since ozone is an active molecule, it loses its effect in a short time and turns into oxygen. is transforming. Ozone is non-storable and has a half-life of 40 minutes at 20°C. It is an unstable gas that must be used at one time due to its For this reason it is generally used where it is produced and in a serial way. In addition, ozone therapy environments such as hospitals or clinics to be performed and applied by experts their usage areas are narrow and their costs are quite high. At the same time, ozone the impracticality of therapy methods and the pain that a person always wants everywhere One of the disadvantages of these methods is that they cannot be applied.
Ozon gazinin tedavi amaciyla kullanimini yayginlastirmak ve eczanelerde satilabilir hale getirmek için ozonun en iyi tasindigi ve uzun süre stabil kaldigi bilinen yaglar kullanilmaktadir. Bunun için ozon gazinin yaglarin içinden geçirilmesi ile ozonlanmis (ozonize/ozonlu) yaglar elde etmektir. Ozon gazi, organik baglar arasinda yüksek reaktivite göstermesi nedeniyle petrokimya ve ilaç endüstride yaygin kullanilmaktadir. To expand the use of ozone gas for treatment and to be sold in pharmacies Oils that are known to carry ozone best and remain stable for a long time to make is used. For this, ozonated gas is ozonized by passing the ozone gas through the oils. (ozonized / ozonized) is to obtain oils. Ozone gas is high between organic bonds. It is widely used in petrochemical and pharmaceutical industries due to its reactivity.
Ozon gazinin, oleik asit reaksiyonu sonrasi kararsiz haline ozonid denir. Criegee reaksiyonu olarak tanimlanan bu tepkimede ozonid, trioksolan benzeri karbonil fragmentleri, aldehit ve peroksitlere dönüsür. Bitkisel yaglarin ozonlanarak kullanilmasi teknigin bilinen durumda mevcuttur. bu ürünlerin farmasötik ve kozmetik amaçlar için kullanimi açiklanmaktadir. Emülsiyon haline getirilmis bitkisel yag ya da yag, reaksiyon sicakliginin kontrolünün saglandigi bir ceket ile kapli köpürtücü bir reaktörde ozonla reaksiyona girmeye yönlendirilmektedir. Ozon, bitkisel yagda veya yagda bulunan çift baglarla reaksiyona girerek, bu ürünlerin biyolojik etkilerinden sorumlu olan farkli peroksidik türlerin olusmasina neden olmaktadir. Ozonlanmis bitkisel yaglar ve yaglar, oftalmoloji, dis hekimi, dermatoloji, gastroenteroloji, jinekoloji, parazitoloji ve digerleri gibi çesitli tibbi uzmanlik alanlarindaki hastaliklarin tedavisinde tatmin edici ve gelismis sonuçlar ile uygulanmaktadir. The unstable state of ozone gas after the oleic acid reaction is called ozonide. criegee In this reaction, which is defined as the reaction, ozonide is formed by trioxolane-like carbonyl fragments are converted to aldehydes and peroxides. The use of vegetable oils by ozonation available in the state of the art. The use of these products for pharmaceutical and cosmetic purposes is described. Emulsion shaped vegetable oil or oil, in which the reaction temperature is controlled to react with ozone in a frothing reactor lined with a jacket. is directed. Ozone reacts with the double bonds found in vegetable oil or oil. different peroxidic species responsible for the biological effects of these products. causing it to occur. Ozonated vegetable oils and fats, ophthalmology, dental physician, dermatology, gastroenterology, gynecology, parasitology, and others. with satisfactory and improved results in the treatment of diseases in their specialty is being implemented.
EP0235528 numarali dokümanda kararli yapida ozonlanmis bitkisel yaglar elde etmek için bitkisel yaglar doygun bir hale gelene kadar ozonlama islemi yapilmaktadir. Bu yöntemde ozon gazi çok yavas bir sekilde belli bir hiz ve sürede yag içerisinden geçirilmektedir. Bitkisel yaglarda bulunan doymamis yag asitleri ozon ile tepkimeye girer ve organik peroksitler ortaya çikar. Ozonlama isleminden sonra kisa zincirli aldehitlerin ozonlanmis yagdan ayrilmasi için asit ortaminda ve bir redoks sistemi varliginda ekstraksiyon islemi gerçeklestirilmektedir. Bitkisel yaglarin ozon ile doyurulmalari katilasmalarina sebep olmaktadir. Bu yüzden bu yöntem ile elde edilen ozonlu yaglar sadece deri yoluyla uygulanabilmektedir. Obtaining stable ozonized vegetable oils in document number EP0235528 For this purpose, ozonation process is carried out until the vegetable oils become saturated. This In this method, ozone gas is very slowly removed from the oil at a certain speed and time. is passed. Unsaturated fatty acids in vegetable oils react with ozone. and organic peroxides are formed. Short chain after ozonation in acid medium and a redox system for the separation of aldehydes from ozonized oil In the presence of the extraction process is carried out. Herbal oils with ozone their saturation causes them to solidify. Therefore, with this method ozonated oils can only be applied through the skin.
TR2010/02961 numarali dokümanda bitkisel yaglarin ozon türevini içeren su bazli kisisel bakim ve temizlik sivisi ve bunun elde etme y'ontemi açiklanmaktadir. In the document numbered TR2010/02961, water-based vegetable oils containing ozone derivatives The personal care and cleaning liquid and the method of obtaining it are explained.
Bahsedilen kisisel bakim ve temizlik sivisi bitkisel yag ozon türevinin, su ve en az bir emülgator ihtiva eden karisim içine eklenmesi ve karistirilmasiyla elde edilmektedir. Mentioned personal care and cleaning liquid vegetable oil ozone derivative, water and at least one It is obtained by adding it to the emulsifier-containing mixture and mixing it.
Bulus konusu karisimda ozonid, su ve emülgatör 35 - 55°C sicaklik araliginda karistirilmakta ve petrol türevleri kullanilmamaktadir. Ilaveten bulus konusu kisisel bakim ve temizlik sivilarini elde etmek için sadece ozonlanmis bitkisel yaglar kullanilmaktadir. Ayrica bu yöntem ile elde edilen karisimlar sadece kozmetik amaçli kullanilmaktadir. In the mixture subject to the invention, ozonide, water and emulsifier are in the temperature range of 35 - 55°C. It is mixed and petroleum derivatives are not used. In addition, the subject of the invention is personal only ozonated vegetable oils to obtain maintenance and cleaning fluids is used. In addition, the mixtures obtained by this method are only used for cosmetic purposes. is used.
Ozonlu yaglar topikal olarak ozon terapinin uygulanmasini kolaylastirmaktadir. Ancak mevcut ozonlu yaglarin kisisel ve evsel kullaniminda bazi zorluklarla karsilasilmaktadir. Ozonated oils facilitate the application of ozone therapy topically. However Some difficulties are encountered in the personal and domestic use of existing ozonated oils.
Ozon reaktif bir molekül oldugu için tibbi amaçli kullaniminda çok dikkat edilmesi gerekmektedir. Kullanilan yaglar tercihen doku uyumlu olmalidir ve uygun dozda ozon içermelidir. Mevcut teknikte ozonlu yaglar genellikle epidermal (deri) yolla uygulanmaktadir. Enjeksiyon yoluyla uygulamalar genellikle ozon/oksijen gazlarinin uygun karisimlarinin tedavi uygulanacak hastanin kaniyla karistirilarak tekrar hastaya geri verilmesi ile yapilmaktadir. Bulus sayesinde enjekte edilebilir yaglarin ozonlanmasiyla elde edilen karisimlar enjeksiyon yoluyla kullanilabilmektedir. Ayrica mevcut teknikte kullanilan ozonlanmis yaglarda yogunlugunun ayarlanmasi ve bahsedilen yaglarin emilim sorunlari bulunmaktadir. Yogun yaglarin kullanilmasi dokulara zarar verirken yaglarin büyük partiküller halinde olmasi emilim sorunlarina yol açmaktadir. Ancak bulus konusu üretim yöntemi ile ozonlanmis yaglar su içerisinde nano veya mikron boyutlara kadar parçalanmaktadir. Böylece dokulara hasar olusma riski ve emilim sorunlarinin üstesinden gelinmektedir. Since ozone is a reactive molecule, great care should be taken when using it for medical purposes. required. The oils used should preferably be tissue compatible and ozone at the appropriate dose. should contain. In the current technique, ozonated oils are usually delivered by epidermal (skin) route. is being implemented. Applications by injection are generally the result of ozone/oxygen gases. The appropriate mixtures are mixed with the blood of the patient to be treated and returned to the patient. done by giving back. Thanks to the invention, injectable oils The mixtures obtained by ozonation can be used by injection. Moreover adjusting the density of ozonated oils used in the current technique and mentioned oils have absorption problems. Using heavy oils While damaging the tissues, the large particles of the oils cause absorption problems. opens. However, with the production method, which is the subject of the invention, ozonized oils are stored in water. disintegrates down to nano or micron sizes. Thus, tissue damage risk and absorption problems are overcome.
Enjekte edilebilen yaglar yillardir yagda eriyen A, D, E, K vitaminleri ve steroidlerin dokuya enjekte edilmesi amaciyla kullanilmaktadir. Enjekte edilebilen yaglarin yan etkilerinin az olmasi nedeniyle ayni yaglarin ozonlanmasi ve suda çözünen nano veya mikron partikül boyutuna sahip ozonlanmis yag veya ozonidlerin olusturulmasi ile kolay enjekte edilen ve miligram cinsinden ölçülebilen bu yaglarin ozon cihazi gerektirmeden eczanelerde satilir hale gelmesiyle yaygin kullanimi amaçlanmaktadir. Ayni zamanda bu uygulama yeni ozon kullanim alanlari yaratilmaktadir. Injectable oils contain fat-soluble vitamins A, D, E, K and steroids for years. It is used for injecting into the tissue. side of injectable oils Ozonation of the same oils and water-soluble nano or Easy to create ozonized oil or ozonides with micron particle size These oils, which can be injected and measured in milligrams, do not require an ozone device. It is aimed to be used widely when it becomes available in pharmacies. At the same time this application creates new ozone usage areas.
Mevcut teknikte meyve ve sebzelerin daha parlak görünmesini saglamak amaciyla üzerine parafin ve benzeri yaglar sikilmaktadir. Bu islem saglik açisindan zararlidir. In order to make fruits and vegetables appear brighter in the current technique, paraffin and similar oils are sprayed on it. This process is harmful to health.
Bitkisel yaglarin ozonlanmasi sonucu olusturulan ozonlanmis yag içeren solüsyonlarinin seyreltik dozlarda ayni amaçla kullanimi meyve sebzelerin raf ömrünü uzatmaktadir. Yag içeriginden dolayi parlak ve saglikli görünmelerini saglamaktadir. Su içeriginden dolayi kurumalarini engellenmektedir. Bulus sayesinde ozonlanmis yag içeren solüsyonlar sikildigi meyve ve sebzelerin üzerinde olusturdugu ince tabaka ile bakteri ve mantar üremesini engellenerek çürüme sürecini geciktirilmektedir. Ayni sekilde etlerin ozon gazindan geçirilerek paketlenmesi raf ömrünü iki kat arttirmaktadir. Containing ozonized oil formed as a result of ozonation of vegetable oils. The use of solutions in diluted doses for the same purpose will increase the shelf life of fruits and vegetables. extends. Due to its oil content, it makes them look bright and healthy. This It is prevented from drying due to its content. Ozonated oil thanks to the invention with the thin layer formed on the fruits and vegetables that are squeezed It prevents the growth of bacteria and fungi and delays the decay process. Same In this way, packaging of meats by passing through ozone gas doubles the shelf life.
Bitkisel kökenli yaglarin ozonlanmasiyla olusturulan ozonlanmis yag içeren solüsyonlarin beyaz ve kirmizi etlerin paketlenmesi esnasinda seyreltik dozlarda ince tabaka halinde sikilmasi etlerin hem canli görünmesini hem de içindeki su içerigiyle kurumasini önleyici etki göstermektedir. Ayni zamanda bakteri, virüs ve mantar kontaminasyonlarini önlemektedir, raf ömrünü uzatmaktadir. Bu besinlerin tüketilmesinde hiçbir sakinca bulunmamaktadir. Bilindigi gibi ozonlanmis yaglar ve bu yaglari içeren solüsyonlar yutuldugunda sindirim sistemini iyilestirici etkileri bulunmaktadir. Paketlenmis yiyeceklerin ve içeceklerin bozulmasini önlemek amaciyla stabilizatör madde olarak ozonlanmis yag içeren solüsyonlarin kullanilmasi hem zararsiz hem de sindirim sistemi ve genel vücut sagligi için yararli bir katki maddesi olmasini saglamaktadir. Bitki ilaçlamasi maliyetli ve kimyasal atiklarin dogaya yayilmasindan dolayi insanlari ve çevreyi olumsuz etkilemektedir. Ozonlanmis yag içeren solüsyonlar ile yapilan ilaçlama tamamen dogal, bitkiye zarar vermeyen ve zararli bakteri ve mantarlarin çürük olusturmasini engelleyen bir etki saglamaktadir. Containing ozonized oil created by ozonation of vegetable oils. thin solutions in diluted doses during packaging of white and red meats. squeezing in layers makes the meat look lively and the water content in it. has an anti-drying effect. Also bacteria, virus and fungus It prevents contamination and prolongs shelf life. These foods There is no harm in its consumption. As it is known, ozonized oils and this Solutions containing oils have digestive effects when swallowed. are available. To prevent spoilage of packaged food and drink The use of solutions containing ozonized oil as a stabilizer a harmless and beneficial additive for the digestive system and general body health makes it happen. Plant spraying is costly and chemical wastes are released to nature. Due to its spread, it affects people and the environment negatively. Ozonated oil Spraying with solutions containing completely natural, plant-free and It provides an effect that prevents harmful bacteria and fungi from forming caries.
Süs bitkilerinin korunmasi ve yaprak sagliginin arttirilmasi amaciyla ozonlanmis yag içeren solüsyonlarin bitki yapraklarina ve gövdesine sikilmasi bitki sagligini arttirici etki saglamaktadir. Ozonated oil to protect ornamental plants and increase leaf health squeezing the solutions containing it on the leaves and stem of the plant has a plant health-enhancing effect. it provides.
Sonuç olarak, yukarida anlatilan olumsuzluklardan dolayi ve mevcut çözümlerin konu hakkindaki yetersizligi nedeniyle ilgili teknik alanda bir gelistirme yapilmasi gerekli kilinmistir. As a result, due to the above-mentioned disadvantages and current solutions It is necessary to make an improvement in the relevant technical field due to the inadequacy of the is locked.
Bulusun Amaci Bulus, mevcut durumlardan esinlenerek olusturulup yukarida belirtilen olumsuzluklari çözmeyi amaçlamaktadir. Purpose of the Invention The invention was created by being inspired by the current situations, and the above-mentioned negativities aims to solve.
Bulusun ana amaci, ozonlanmis yaglarin su içerisinde nano veya mikron boyutlara kadar parçalanmasini saglayarak birçok alanda kullanilmasina olanak saglamaktir. The main purpose of the invention is to convert ozonized oils to nano or micron sizes in water. It is to enable it to be used in many areas by allowing it to be broken down until it is broken down.
Ozellikle ozonun dokulara hasar verme ve emilim sorunlarinin üstesinden gelmektir. In particular, it is to overcome the tissue damage and absorption problems of ozone.
Bulusun bir diger amaci, enjeksiyon amaciyla kullanilan yaglarin ozonlanmasiyla elde edilen nano veya mikron boyutlarda ozonlanmis yag veya ozonid içeren solüsyonlarin hazirlanarak tek baslarina veya uygun maddeler ile karisim halinde dokulara enjekte edilebilmesini saglamaktir. Another object of the invention is obtained by ozonation of oils used for injection. solutions containing ozonized oil or ozonide in nano or micron sizes. It is prepared and injected into the tissues alone or in a mixture with appropriate substances. is to make it possible.
Bulusun bir diger amaci, bulus konusu ozonlanmis yag veya ozonid içeren solüsyonlarin birden fazla yag içeren karisimlarinda (çoklu karisim) her bir yagin yan etkilerini azaltilmasini saglamaktir. Tüm uygulamalarda bulus konusu ozonlanmis yag veya ozonid içeren solüsyonlarin birey veya kombinasyonlari (biri veya hepsi) karistirilarak kullanilabilir. Another object of the invention is the subject of the invention ozonized oil or ozonide-containing in mixtures of solutions containing more than one oil (multi-mixture) to reduce its effects. In all applications, the subject matter of the invention is ozonized oil. or individual or combinations (one or all) of ozonide-containing solutions can be used by mixing.
Bulusun bir diger amaci, ozonlanmis yagin gram cinsinden ölçülerek aldigi ozon miktari ölçülebilmesi sayesinde bulus konusu yöntemlerin güvenli kullanimini saglamaktir. Çünkü yaglarin ozonlanmasi sonucu agirliklari artmaktadir. Another object of the invention is ozone, which is obtained by measuring the ozonized oil in grams. safe use of the inventive methods by measuring the amount of is to provide. Because as a result of ozonation of oils, their weight increases.
Bulusun bir diger amaci, enjekte edilebilir yaglarla olusturulan ozonlanmis yag veya ozonidlerin dokulardaki emilimini arttirmak amaciyla suda çözülerek 100 - 400 mikronluk veya ultrasonik yöntemlerle 1 nanometre partikül boyutuna kadar parçalanmis ozonlanmis yag veya ozonid halinde enjektabl kullanimini mümkün hale getirmektedir. Bu yeni ürün ozonlanmis yag içeren solüsyon (veya ozonid solüsyonu) olarak adlandirilmaktadir. Çesitli yöntemler kullanilarak ozonlanmis yag veya ozonidler 1 nanometreden 400 mikrometreye kadar genis bir aralikta partikül boyutuna parçalanabilmektedir. Another object of the invention is ozonized oil or oil formed with injectable oils. In order to increase the absorption of ozonides in the tissues, it is dissolved in water 100 - 400 up to 1 nanometer particle size by micron or ultrasonic methods It makes possible the use of injectables in the form of fragmented ozonized oil or ozonide. brings. This new product is a solution (or ozonide solution) containing ozonized oil. is named. Oil or ozonides ozonized using various methods A wide range of particle sizes from 1 nanometer to 400 micrometer can be fragmented.
Bulusun bir diger amaci, su içerisinde yag çözeltileri yüksek çözünürlükte 1 nanometre - 400 mikrometre büyüklük araliginda nano veya mikron partikül boyutununa sahip ozonlanmis yag veya ozonidler olusturmaktadir. Bu ozonlanmis yag veya ozonid çözeltileri intramuskuler, intraartikuler, lokal etki amaciyla, yara tedavisinde bölgesel enjeksiyon yoluyla, burun damlasi sprey, kulak damlasi, göz damlasi, agiz içi yaralarda, rektal yikama ve ozonlama, rektal suppozituar, vagen temizligi ve uterus içi enjeksiyonunda solüsyon olarak ve vaginal ovuI ve suppozituar olarak, mesane içine, idrar sondasi için Iubrikant, mezoterapi amaciyla bölgesel enjeksiyon, saç gelistirme amaciyla enjeksiyon ve her türlü harici kullanimda etkisini kombine etmek amaciyla tek ya da diger ilaçlarla birlikte bir ya da birden çok enjekte edilebilen ozon yagiyla yapilan karisim kullanilabilmektedir. Another object of the invention is oil-in-water solutions with high solubility of 1 nanometer. - Has nano or micron particle size in the 400 micrometer size range forms ozonized oil or ozonides. This ozonized oil or ozonide solutions intramuscular, intraarticular, for local effect, regional in wound treatment by injection, nasal drops spray, ear drops, eye drops, intraoral in wounds, rectal washing and ozonation, rectal suppository, vaginal cleaning and intrauterine as a solution for injection and as a vaginal ovule and suppository, into the bladder, Iubrikant for urinary catheter, regional injection for mesotherapy, hair growth In order to combine its effect in injection and all kinds of external use, it is a single or with one or more injectable ozone oil with other drugs mix can be used.
Bulusun bir diger amaci, tüm bitkisel ve kimyasal yaglarin ozonlanmasi sonucu olusan ozonlanmis yag veya ozonidlerin nano veya mikron partikül haline getirilmesi doza ve solüsyon yogunluguna göre degisen oranlarda kimya, kozmetik, tarim, hayvancilik sektörlerinde kullanilmasini saglamaktir. Another object of the invention is the ozonation of all vegetable and chemical oils. Turning ozonized oil or ozonides into nano or micron particles depends on dose and chemistry, cosmetics, agriculture, animal husbandry at rates varying according to solution density. to ensure its use in the sectors.
Bulusun bir diger amaci, lokal anestezik, antiinflamatuar gibi etkisinin uzamasi gereken ilaçlarla birlikte kullanilabilmesidir. Bulus konusu ozonlanmis yag solüsyonlarinin yogun olan karisimlari intramüsküler, intraartikuler ya da lokal bölge enjeksiyonlarinda, 72 saat gibi süreler ozon salgilamaktadir. Another aim of the invention is that the effect of local anesthetic, anti-inflammatory, etc. should be prolonged. can be used with drugs. Dense concentration of ozonized oil solutions of the invention mixtures with intramuscular, intraarticular or local site injections, 72 Periods such as hours release ozone.
Bulusun bir diger amaci, tüm yagda çözünen vitaminler ve ilaçlarla kombine edilerek ozonlanmis yaglarin kullanilmasini saglamaktir. Another object of the invention is to combine it with all fat-soluble vitamins and drugs. to ensure the use of ozonized oils.
Bulus, düsük dozlarda ve yavas verildiginde parenteral ozon vermek amaciyla kullanilabilmektedir. The invention is intended for parenteral ozone delivery at low doses and slow administration. can be used.
Bulusun bir diger amaci, kolesterol, trigliserid, fosfolipid gibi yaglarin yüksek ozonlanmasi, K vitaminiyle kombine arterial damar tikanikliginda intra arterial verilmesi damar cidarina yapisan ozonlu yag ürünlerinin antioksidan etkisi ile damarin açilmasini saglamaktir. Another aim of the invention is to provide high levels of fats such as cholesterol, triglycerides, phospholipids. ozonation, intra-arterial administration in arterial occlusion combined with vitamin K It prevents the opening of the vein with the antioxidant effect of ozonated oil products adhering to the vein wall. is to provide.
Bulusun bir diger amaci, bölgesel enfeksiyonlarda antibiyotik kullanimini azaltmaktir. Another aim of the invention is to reduce the use of antibiotics in regional infections.
Bulus konusu ozonlanmis yag içeren solüsyonlarinin enjeksiyonu yavas salinim yapacagindan oksijenlenmeyi arttirarak antibiyotik kullanimini azaltmaktadir. Apse içine ve çevresine enjeksiyon seklinde uygulanabilmektedir. Ameliyat yara iyilesmesini arttirmak amaciyla ameliyat bölgesine enjekte edilebilmektedir. Injection of solutions of the invention containing ozonized oil, slow release It will increase oxygenation and reduce the use of antibiotics. Abscess It can be applied as an injection into and around it. surgery wound healing It can be injected into the surgical area to increase
Bulusun bir diger amaci, ozonlanmis yag içeren solüsyonlarin yara tedavisinde hem lokal enjeksiyon yoluyla hem de yüzeysel olarak kullanilmasini saglamaktir. Another aim of the invention is to use solutions containing ozonized oil both in wound treatment. It is to ensure that it is used both superficially and by local injection.
Bulusun bir diger amaci, zayiflama amaciyla mezoterapi için bölgesel kullanilan soya ozonlanmasini saglayarak etkilerini arttirmaktir. Another object of the invention is soybean, which is used locally for mesotherapy for weight loss. to increase its effects by providing ozonation.
Bulusun bir diger amaci, ozonlanmis yag içeren solüsyonlarin saç dökülmesinde mezoterapi amaciyla tek basina ya da diger ilaçlarla kombine kullanilmasini saglamaktir. Another object of the invention is to use solutions containing ozonized oil in hair loss. to be used alone or in combination with other drugs for mesotherapy is to provide.
Bulusun bir diger amaci, silikon yaginin ozonlanmasiyla olusan ozonlanmis yag veya ozonid içeren solüsyonlari ve diger ozonlanmis yag veya ozonidleri cilt mezoterapisinde kullanmaktir. Another object of the invention is ozonized oil or gas formed by ozonation of silicon oil. ozonide-containing solutions and other ozonated oils or ozonides to use in mesotherapy.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin mastit tedavisinde lokal fistül içi enjeksiyon ve bölgesel enjeksiyon seklinde uygulanmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. local intra-fistula injection and regional injection in the treatment of mastitis is to ensure its implementation.
Bulusun bir diger amaci, ozonlanmis yag içeren solüsyonlarin düzenli enjeksiyonu ile antioksidan etkinin arttirilarak kanser 'önleme ve kemoterapiye ek olarak kullanilmayi saglamaktir. Another object of the invention is the regular injection of solutions containing ozonized oil. to be used in addition to cancer prevention and chemotherapy by increasing the antioxidant effect. is to provide.
Bulusun bir diger amaci, kanser tedavisinde bölgesel olarak kanserli dokuya ve çevre dokuya yüksek yogunlukta yüksek dozda verilerek kanser dokusunu hipoksik hale getirmektir. Another object of the invention is to locally treat cancerous tissue and the environment in the treatment of cancer. It makes the cancer tissue hypoxic by giving high concentration to the tissue in high doses. is to bring.
Bulusun bir diger amaci, kanser tedavisinde ozonlanmis yag solüsyonunun kemoterapi ilaçlariyla kombine edilmesiyle kanser hücresinin oksijen alma kapasitesinin yüksek oldugu düsünülerek hücre içine kemoterapik ajani sokan selektif bir ilaç olmasini saglamaktir. Another object of the invention is the use of ozonized oil solution in the treatment of cancer chemotherapy. By combining it with drugs, the oxygen uptake capacity of the cancer cell is high. It is a selective drug that introduces the chemotherapeutic agent into the cell, assuming that it is is to provide.
Bulusun bir diger amaci, genel amaçlarla ozon kullaniminda haftada 2 - 3 kez yapilan ozonlama ile major terapi etkisinin intramüsküler ya da subkutan uygulamayla saglamaktir. Another aim of the invention is to use ozone for general purposes 2-3 times a week. With ozonation, the major therapeutic effect is achieved by intramuscular or subcutaneous administration. is to provide.
Bulusun bir diger amaci, ozonlanmis yag veya ozonid içeren solüsyonlarin, intravenöz yolla uygulamasinda sudaki nano veya mikron boyuttaki ozonlanmis yag partikülleri kullanilarak az dozlarda hizli çözünme saglanarak ozonun akciger dokusuna ulasmadan çözünmesini saglamaktir. Böylece kan transfüzyonu yerine ozonlanmis yag içeren solüsyonlarin kullanilmasi saglanmaktadir. Another object of the invention is that solutions containing ozonized oil or ozonide are administered intravenously. ozonized oil particles in nano or micron size in water By using low doses, rapid dissolution is ensured and ozone is transferred to the lung tissue. is to ensure that it dissolves before it reaches it. Thus, instead of blood transfusion, ozonized oil The use of solutions containing
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin eklem içi enjeksiyonlarda kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used in intra-articular injections.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin bel ve boyun fitiklarinda daha etkili olmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. is to ensure that the solutions are more effective in waist and neck hernias.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kirik kaynamasinda ve 'özellikle kirik kaynamasinda bölgesel enjeksiyonlarda kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. localized solutions in fracture union and 'particularly in fracture union' to ensure its use in injections.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin yara tedavisinde, özellikle bölgesel enjeksiyon ve yüzeysel uygulamalarda, daha etkili olmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. solutions in wound treatment, especially regional injection and superficial in applications, to ensure that it is more effective.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin tüm harici formlar ve mukozal formlarda gümüs nano patiküller veya diger oligodinamik etki gösteren metaller ile birlikte kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. silver nanoparticles or in all external forms and mucosal forms of the solutions It is to ensure that it is used together with other metals with oligodynamic effects.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin tenosinovit, fibromiyalji, miyozit, plantar fasciitis gibi hastaliklarin tedavisinde enjekte edilebilir olarak daha etkili kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. the solutions of diseases such as tenosynovitis, fibromyalgia, myositis, plantar fasciitis It is to ensure that it is used more effectively as an injectable in the treatment.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin sonda uygulamalarinda Iubrikant olarak kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used as Lubricant in catheter applications.
Bulusun bir diger amaci, sistit, üretrit, üreterit tedavisinde mesane içi nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kullanimini saglamaktir. Another aim of the invention is intravesical nano or micron in the treatment of cystitis, urethritis, ureteritis. To ensure the use of solutions containing ozonized oil in different sizes.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin vulvovaginit ve vaginit tedavisinde kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that solutions are used in the treatment of vulvovaginitis and vaginitis.
Bulusun bir diger amaci, 'özellikle nano veya mikron boyutlarda ozonlanmis hashas yagi içeren solüsyonlarin infertilite (kisirlik) tedavisinde kullanilmasini saglamaktir. Another object of the invention is the use of 'ozonized flakes', especially in nano or micron sizes. It is to ensure that solutions containing oil are used in the treatment of infertility.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin pelvik inflamatuar hastaliklarda kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used in pelvic inflammatory diseases.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin göz hastaliklarinda kullanilmasini saglamaktir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar g'oz enfeksiyonlarinda, alerjik göz hastaliklarinda, otoimmun göz hastaliklarinda ve benzeri göz hastaliklarinda tercihen göz damlasi veya farkli formlarda kullanilabilmektedir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used in eye diseases. nano or micron solutions containing ozonized oil in different sizes, in eye infections, allergic eye preferably in autoimmune eye diseases and similar eye diseases It can be used as eye drops or in different forms.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kulak ile ilgili hastaliklarda kullanilmasini saglamaktir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar dis, orta kulak enfeksiyonu ve benzeri kulak ile ilgili hastaliklarda tercihen kulak damlasi veya farkli formlarda kullanilabilmektedir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used in diseases related to the ear. nano or micron solutions containing ozonized oil in different sizes, such as dental, middle ear infections and similar in ear-related diseases, preferably as ear drops or in different forms. can be used.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin burun ile ilgili hastaliklarda kullanilmasini saglamaktir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar sinüzit, nezle, alarjik rinit ve benzeri burun ile ilgili hastaliklarda tercihen burun damlasi, spreyi veya farkli formlarda kullanilabilmektedir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used in diseases related to the nose. nano or micron solutions containing ozonized oil in different sizes, such as sinusitis, catarrh, allergic rhinitis and similar in nasal diseases, preferably in nasal drops, sprays or in different forms. can be used.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin grip tedavisinde tercihen sprey veya farkli formlarda kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. It is recommended that the solutions be used in the treatment of flu, preferably in spray or different forms. is to provide.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin bogaz enfeksiyonlarinda pastil veya farkli formlarda kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. to use the solutions as lozenges or in different forms in throat infections. is to provide.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin agiz ve dis hastaliklarinin tedavisinde kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. To ensure that the solutions are used in the treatment of oral and dental diseases.
Somatit, gingivit gibi hastaliklarin tedavisinde nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kullanilabilmektedir. Dis çürüklerinde kavite içine nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar uygulanabilmektedir. Dis tedavilerinde nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar lokal anestezikle birlikte kullanilabilmektedir. Dis apselerinin tedavisinde nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar enjeksiyon yoluyla kullanilabilmektedir. Ozonated in nano or micron sizes in the treatment of diseases such as somatitis and gingivitis. Oil-containing solutions can be used. In dental caries, nano or Solutions containing ozonized oil in micron sizes can be applied. External solutions containing ozonized oil in nano or micron sizes It can be used with an anesthetic. Nano or micron treatment of dental abscesses Solutions containing ozonized oil can be used by injection.
Dis çekimi sonrasinda ve alveolid tedavisinde nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar kullanilabilmektedir. Ozonated in nano or micron sizes after tooth extraction and in the treatment of alveoli Oil-containing solutions can be used.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin mide hastaliklarinda, helicobacter pylori eradikasyonunda midede eriyen kapsül veya farkli formlarda kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. solutions that dissolve in the stomach in stomach diseases, eradication of helicobacter pylori is to ensure that it is used in capsules or in different forms.
Bulusun bir diger amaci, genel kullanim amaçli sistemik etkisi olan bagirsakta çözülen nano veya mikron boyutlarda ozonlanmis yag veya ozonid içeren solüsyonlarin kapsül veya farkli formlarda kullanmasini saglamaktir. Another object of the invention is to dissolve in the intestine, which has a systemic effect for general use. Encapsulation of solutions containing ozonized oil or ozonide in nano or micron sizes or to use it in different forms.
Bulusun bir diger amaci, hemoroid, fistül, fissür, anal apse ve benzeri hastaliklarin tedavisinde nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin fitil veya farkli formlarda kullanilmasini saglamaktir. Another aim of the invention is to treat hemorrhoids, fistula, fissure, anal abscess and similar diseases. in the treatment of solutions containing ozonized oil in nano or micron sizes, suppositories or to enable it to be used in different forms.
Bulusun bir diger amaci, kolitis ülseroza, crohn hastaligi tedavisinde ve genel ozonun bagirsaktan emilimini gerçeklestirmek üzere nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin fitil veya farkli formlarda kullanilmasini saglamaktir. Another object of the invention is the treatment of colitis ulcerosa, crohn's disease and general ozone. Ozonated in nano or micron sizes to absorb from the gut It is to ensure that solutions containing oil are used as suppositories or in different forms.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin rektal yikama ve Iavman için kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. is to ensure that the solutions are used for rectal washing and irrigation.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin peritonidlerde intraperitoneal enjeksiyonun kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. is to provide the use of intraperitoneal injection of solutions in the peritonids.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren seyreltik solüsyonlarin parenteral yolla kullanilmasini saglamaktir. Another object of the invention is the use of dilute oil containing ozonized oil in nano or micron sizes. It is to ensure that the solutions are used parenterally.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kozmetik ürünlerde kullanilarak bu ürünlerin deri emilimlerini arttirmayi saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. It is aimed to increase the skin absorption of these products by using the solutions in cosmetic products. is to provide.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin bagirsak, mesane, vagen dokusu, rektal doku, agiz ve burun mukozasi, göz ve kulak gibi hassas dokularda istenilen yogunlukta kolaylikla kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. intestinal, bladder, vaginal tissue, rectal tissue, oral and nasal mucosa, It can be easily used at the desired density in sensitive tissues such as eyes and ears. is to provide.
Bulusun bir diger amaci, tibbi kullanimda eklem içi enjeksiyonlarda istenilen dozda su orani yüksek karisimlarin hazirlanmasina imkan saglamaktir. Another aim of the invention is to use water in the desired dose in intra-articular injections in medical use. It is to allow the preparation of mixtures with high ratios.
Bulusun bir diger amaci, insülin gibi yavas emilimi ve uzun salinimi istenen ilaçlarin bulus konusu ozonlanmis yag içeren solüsyonlar ile kullanilmasini saglayarak uzun etkili olmasi saglamaktir. Another object of the invention is to administer drugs that require slow absorption and prolonged release, such as insulin. The subject of the invention provides long-lasting use with solutions containing ozonized oil. is to make it effective.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin veterinerlikte enfeksiyonlari 'Önlemek amaciyla antibiyotik yerine kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. solutions instead of antibiotics to prevent infections in veterinary medicine. to ensure its use.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin hayvan sagligi gelisimini arttirmak amaciyla yemlere ve içme sularina karistirilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. solutions to feed and drinking water to increase animal health improvement. is to ensure that it is mixed.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin veterinerlikte mastitlerde bölgesel enjeksiyonunu ve kavite içine uygulamasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. local injection of solutions in veterinary mastitis and intracavity to ensure its application.
Bulusun bir diger amaci, veterinerlikte vagina enfeksiyonlarinda vaginal ozonlanmis yag veya ozonid içeren solüsyonlarin fitil veya farkli formlarda uygulanmasini saglamaktir. Another aim of the invention is to use vaginal ozonated in veterinary vagina infections. Application of solutions containing oil or ozonide in suppository or different forms. is to provide.
Bulusun bir diger amaci, veterinerlikte lokal enfeksiyonlarda, apse tedavisinde bölgesel ozonlanmis yag içeren solüsyonlarin enjeksiyonunun uygulanmasini saglamaktir. Another aim of the invention is to treat local infections in veterinary, regional abscess treatment. It is to provide the injection of solutions containing ozonized oil.
Bulusun bir diger amaci, veterinerlikte eklem hasarlarinda ve tendinitlerde ozonlanmis yag içeren solüsyonlarin enjeksiyonunun uygulanmasini saglamaktir. Another object of the invention is to use ozone in veterinary joint injuries and tendinitis. It is to provide the injection of solutions containing oil.
Bulusun bir diger amaci, kozmetik, gida, veterinerlik, tip ve ilaç sektöründe, tarim ilaçlarinda vb. uygulama alanlarinda kullanilabilir, ayarlanabilir dozlarda nano veya mikron boyutlarda ozonlanmis yag içeren `ürünler hazirlamaktir. Another object of the invention is in the cosmetics, food, veterinary, medical and pharmaceutical industries, agriculture in medicines etc. It can be used in the application areas, nano or nano in adjustable doses. is to prepare products containing ozonized oil in micron sizes.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlardan tek kullanimlik poset mendil olusturulmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. It is to provide the creation of disposable tissue paper from solutions.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlardan tek kullanimlik ambalaj solüsyonlar olusturmaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. is to create single-use packaging solutions from solutions.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin vaginal tek kullanimlik hijyenik karisimlarini olusturmaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. is to create vaginal disposable hygienic mixtures of solutions.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yaglarin içeren solüsyonlarin gargara formunda kullanilmasini saglamaktir. Another object of the invention is to produce ozonized oils in nano or micron sizes. is to ensure that the solutions are used in the form of mouthwash.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yaglarin içeren solüsyonlarin kozmetik preparatlar hazirlanmasinda, cilt bakimi ve tedavisinde kullanilmasini saglamaktir. Another object of the invention is to produce ozonized oils in nano or micron sizes. in the preparation of cosmetic preparations of solutions, skin care and treatment to ensure its use.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin içeceklere karistirilarak kullanilmasini saglamak için tek kullanimlik ambalajlarin hazirlanmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. disposable to allow solutions to be mixed into drinks to ensure that the packaging is prepared.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar ihtiva eden içecekler hazirlanmaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. Drinks containing solutions are prepared.
Bulusun bir diger amaci, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin temizlik maddeleriyle karistirilarak kullanilmasini saglamaktir. Another object of the invention is to contain ozonized oil in nano or micron sizes. It is to ensure that the solutions are used by mixing them with cleaning agents.
Bulusun bir diger amaci, nano veya mikron boyutlarda bitkisel kökenli ozonlanmis yag içeren solüsyonlari meyve ve sebzelerin 'üzerine sikarak hem daha parlak bir görünüm hem de raf ömürlerinin uzamasini saglamaktir. Another object of the invention is ozonated oil of vegetable origin in nano or micron sizes. By squeezing the solutions containing the fruit and vegetables on the fruit and vegetables, you can get a brighter appearance. as well as prolonging their shelf life.
Bulusun bir diger amaci, et, balik vb. hayvansal gidalar 'üzerine nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin sikilarak raf ömürlerinin uzamasini saglanmaktir. Another object of the invention is meat, fish, etc. nano or micron on animal foods' Extending shelf life by squeezing solutions containing ozonized oil is to be provided.
Bulusun bir diger amaci, bitkilerin ilaçlanmasinda ve organik tarim uygulamalarinda nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kullanilmasini saglamaktir. Another aim of the invention is to use pesticides in plants and organic farming applications. the use of solutions containing ozonized oil in nano or micron sizes. is to provide.
Bulusun bir diger amaci, tavuk yetistiriciliginde nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kullanilmasini saglamaktir. Another object of the invention is to use nano or micron sizes in chicken breeding. To ensure the use of solutions containing ozonized oil.
Yukarida anlatilan amaçlari yerine getirmek 'üzere bulus, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar olup; yag, ozon gazi, distile su ve en az bir adet em'ulgat'or içermektedir. In order to fulfill the above-described purposes, the invention is made in nano or micron sizes. are solutions containing ozonized oil; oil, ozone gas, distilled water and at least one Contains em'ulgat'or.
Bulusun yapisal ve karakteristik 'özellikleri ve tüm avantajlari asagida verilen sekiller ve bu sekillere atiflar yapilmak suretiyle yazilan detayli açiklama sayesinde daha net olarak anlasilacaktir ve bu nedenle degerlendirmenin de bu sekiller ve detayli açiklama göz önüne alinarak yapilmasi gerekmektedir. The structural and characteristic features and all advantages of the invention are given in the following figures and It is clearer thanks to the detailed explanation written by making references to these figures. will be understood as such, and therefore the assessment will also include these figures and should be taken into account.
Bulusun Detayli Açiklamasi Bu detayli açiklamada, bulusa konu olan nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin, bunlarin 'üretim metotlarinin ve kullanim alanlarinin tercih edilen yapilanmalari, sadece konunun daha iyi anlasilmasina yönelik olarak açiklanmaktadir. Detailed Description of the Invention In this detailed description, ozonized oil in nano or micron sizes, which is the subject of the invention, preferred solutions, their production methods and areas of use. their configuration is explained only for a better understanding of the subject.
Bilinen ozonlanmis yag veya ozonid kullanimlari yara tedavisi, deri hastaliklari, kozmetik amaçli, sindirim sistemi yoluyla kullanimi seklinde tanimlanmaktadir. Known ozonized oil or ozonide uses are used in wound treatment, skin diseases, It is defined as use for cosmetic purposes through the digestive system.
Parenteral yolla ozon uygulamasi, lokal enjeksiyonla ozon uygulamasi, rektal ozon uygulamasi, major terapi, minör terapi, torba ve kupa ile bölgesel ozon uygulamalari baslica ozon uygulama yöntemleridir, Ancak bu uygulamalarin yapilmasi için ozon cihazi olan bir klinik ya da hastaneye ihtiyaç vardir. Hedeflenen tedavi yöntemi ozonun tasinabilir flakon ya da ampullerle eczanelerde satilabilir hale getirilerek yaygin kullanimini saglamaktir. Ayni zamanda veterinerlik, gida sanayi, beslenme solüsyonlari, kimya sanayinde, tarimda kullanilabilir ve marketlerde satilabilir ürünler haline getirmektir Ozonlanmis yag içeren solüsyonlarin hazirlanmasinda ozonun en iyi tasindigi ve uzun süre stabil kaldigi bilinen yaglar, ozonlanma islemine tabi tutulmaktadir. Yaglarin ozonlanmasiyla ozonid denilen yapilar olusmaktadir. Temel olarak tüm yaglarin ozonlanabildigi bilinmektedir. Bulus konusu ozonlanmis yag içeren solüsyonlarda kullanilan yaglar enjekte edilebilir yaglar ve enjekte edilemeyen yaglar olmak üzere ikiye ayrilmaktadir. Enjeksiyon amaciyla kullanilmakta olan bitkisel kökenli yaglar soya yagi, susam yagi, palmiye yagi, hashas yagi, soya Iesitin, kolesterol, b-sterol, trigliserid, zeytin yagi, balik yagi, ayçiçek yagi, hint yagi, safran yagi (safflower), hindistan cevizi yagi, trigliserid türevleri, tributirin, tricaproin, tricaprylin, bitkisel ve hayvansal yaglarin damar yolundan beslenme amaciyla verilmesi için 70 kg'lik bir insan için günlük beslenme solüsyonlarina 175 grama kadar yag emulsiyonu verilmesi yayginlasmis bir yöntemdir. Kimya sanayinde kullanilan parafin (mineral oil), etil oleat, metil oleat gibi hidrokarbon yaglar gibi tüm enjekte edilebilir yaglarin ozonlanmasi sonucu yag içinde olusan ozon kabarciklari ile olusturulan ozonidler her yagin kendine özgü yan etkilerinden kurtulmak amaciyla belli dozlarda karistirilarak ya da tek tek kullanilmaktadir. Parenteral ozone administration, local injection ozone administration, rectal ozone application, major therapy, minor therapy, bag and cup and regional ozone applications are the main ozone application methods, However, ozone application is required for these applications. A clinic or hospital with a device is needed. Targeted treatment method ozone It is widely used by making it available for sale in pharmacies with portable vials or ampoules. to ensure its use. At the same time, veterinary medicine, food industry, nutrition solutions, products that can be used in the chemical industry, agriculture and can be sold in markets is to make In the preparation of solutions containing ozonized oil, ozone is best transported and long Oils that are known to remain stable for a long time are subjected to ozonation process. your oils With ozonation, structures called ozonides are formed. Basically all oils It is known to be ozonized. The subject of the invention is in solutions containing ozonized oil. The oils used are injectable oils and non-injectable oils. is divided into two. Vegetable oils used for injection are soybean oil. oil, sesame oil, palm oil, hash oil, soybean oil, cholesterol, b-sterol, triglyceride, olive oil, fish oil, sunflower oil, castor oil, safflower oil (safflower), coconut oil, triglyceride derivatives, tributyrin, tricaproin, tricaprylin, herbal and a 70 kg container for intravenous feeding of animal fats. up to 175 grams of fat emulsion to human nutrition solutions daily It is a common method. Paraffin (mineral oil), ethyl oleate, used in the chemical industry, ozonation of all injectable oils such as hydrocarbon oils such as methyl oleate The ozonides formed by the ozone bubbles formed in the oil as a result of In order to get rid of its specific side effects, it can be mixed in certain doses or individually. is used.
Enjekte edilemeyen yaglarin ozonlanmasiyla elde edilen karisimlar genellikle krem, merhem vb. yari kati yari sivi formda kullanilarak kozmetik ve yara tedavisi amaciyla kullanilmaktadir. Mevcut tekniklerle elde edilen ozonlanmis yaglar ve ozonidler ile enjekte edilebilir solüsyonlar hazirlanamamaktadir. Mevcut teknik ile hazirlanan ozonlanmis yaglar ve ozonidler enjeksiyon yoluyla kullanildiklarinda yakici etkileri nedeniyle dokulara zarar vermekte ve düsük emilim göstermektedir. Kullanilan tüm yaglar içerigine göre farkli oranlarda ozonlanma islemine tabi tutulmaktadir. Mixtures obtained by ozonation of non-injectable oils are usually cream, ointment etc. It is used in semi-solid, semi-liquid form for cosmetic and wound treatment. is used. With ozonized oils and ozonides obtained by existing techniques Injectable solutions cannot be prepared. prepared with the current technique Burning effects of ozonated oils and ozonides when used by injection It causes damage to tissues and shows low absorption. All used Oils are subjected to ozonation process at different rates according to their content.
Enjekte edilebilir yaglarin bitkisel ve kimyasal kökenli olanlari bulunmaktadir. Bitkisel kökenli yaglar ozonlama sirasinda ekzotermik reaksiyon vererek disariya isi vermektedirler. Bu yüzden bitkisel kökenli yaglarin ozonlanmasi sirasinda sogutma islemi uygulanmalidir. Bitkisel kökenli yaglarin uzun süre ozonlanmasi katilasmalarina neden olmaktadir. Bu durumda enjekte edilebilir olmalari mümkün degildir. Parafin gibi petrol türevi kimyasal kökenli yaglar ozonlanirken ekzotermik reaksiyon vermezler ve yogunluklari çok fazla degismez. Ancak bu petrol türevi yaglarin da yogun ozonlu formunun enjekte edilmesi dokulara zarar vermektedir. Ayrica yaglarin ve ozonidlerin büyük partiküller halinde olmasi emilimlerini zorlastirmaktadir. There are injectable oils of vegetable and chemical origin. Vegetable Originated oils give out heat by giving exothermic reaction during ozonation. they give. Therefore, during the ozonation of vegetable oils, cooling should be applied. Long-term ozonation of vegetable-derived oils causes their solidification. causes. In this case, it is not possible for them to be injectable. like paraffin Petroleum derived chemical oils do not give an exothermic reaction while ozonized and their density does not change much. However, these petroleum-derived oils are also heavily ozonated. Injection of the form damages the tissues. In addition, oils and ozonides Being in the form of large particles makes their absorption difficult.
Ozonlanmis yag içeren solüsyonlar yag, ozon gazi, distile su ve emülgatör içermektedir. Bulusun tercih edilen bir uygulamasinda ozonlanmis yag içeren solüsyonlar kullanim alanina göre farkli katki maddeleri de içerebilmektedir. Bulus konusu ozonlanmis yag içeren solüsyonlar nano veya mikron boyutlarda yag ve ozonid içermektedir. Bahsedilen solüsyonlar 1 nanometre - 400 mikrometre araliginda partikül boyutuna sahip ozonlanmis yag içeren solüsyonlardir. Bu özellikleri nedeniyle bu solüsyonlar enjeksiyon yoluyla kullanilmaya uygundur. Bulus konusu ozonlanmis yag içeren solüsyonlarin içerik ve kullanim miktarlari Tablo 1ide verilmektedir. Solutions containing ozonized oil are oil, ozone gas, distilled water and emulsifier. contains. In a preferred embodiment of the invention, it contains ozonized oil. The solutions may also contain different additives according to the usage area. Meet Solutions containing ozonized oil, oil and ozonide in nano or micron sizes contains. The solutions mentioned are particles in the range of 1 nanometer - 400 micrometer. They are solutions containing ozonized oil with the same size. Because of these features, it The solutions are suitable for use by injection. The subject of the invention is ozonized oil The content and usage amounts of the solutions containing it are given in Table 1.
Tablo 1: Içerik ve kullanim miktarlari Içerik Agirlikça Tercih Edilen Agirlikça Kullanilabilir Miktar (%) Miktar (%) Ozon gazi 2 0,1 - 5 Distile su 76 40 - 97,9 Emülgatör 2 1 - 5 Bulusun tercih edilen uygulamalarinda enjeksiyon için kullanilan vücuda zararlari yönünden çalismalari yapilmis yaglar ozonlanmaktadir. Bu yaglardan bitkisel olanlari ozonlanma asamasinda ekzotermik reaksiyon olusturmakta ve yogunluklari artmaktadir. Ancak hidrokarbon türevleri (kimyasal kökenli yaglar) ekzotermik reaksiyon olusturmamakta, yapilari ve yogunluklar degismemektedir. Table 1: Content and usage amounts Content Can Be Used By Weight Preferred By Weight Amount (%) Amount (%) Ozone gas 2 0.1 - 5 Distilled water 76 40 - 97.9 Emulsifier 2 1 - 5 Harms to the body used for injection in preferred embodiments of the invention Oils that have been studied in terms of Herbal ones from these oils forms an exothermic reaction in the ozonation stage and their density increases. increasing. However, hydrocarbon derivatives (oils of chemical origin) are exothermic. they do not form a reaction, their structures and densities do not change.
Ozonlama isleminde ozon kaynagi olarak ozon jeneratörleri kullanilmaktadir. Bu cihazlardan elde edilen ozon/oksijen karisimi ile ozonlama islemi yapilmaktadir. In ozonation process, ozone generators are used as ozone source. This The ozonation process is carried out with the ozone/oxygen mixture obtained from the devices.
Yapilan uzun ozonlama islemlerinde, islem öncesi ve sonrasi yaglar hassas terazi ile tartildiginda bitkisel yaglarda 160 mg/gr; hidrokarbon yaglarda 120mg/gr yogunlukta ozon olustugu gözlenmektedir, Bu durum yag içinde ozon miktarinin ölçülmesi için iyi ve güvenli bir ölçüm yöntemi olusturmaktadir. Enjeksiyon uygulamalarinda da hesaplamalar mikrogram üzerinden yapilmaktadir. Ornegin, major terapinin bir seansinda 30 mikrogram yogunlugunda ozon 100 ml (cc) uygulanmakta yani toplamda 3 mg ozon oksijenle karisim halinde verilmektedir. Lokal uygulamalarda da yaklasik ayni dozlar kullanilmaktadir. Ayni dozlarda ozonlanmis yag veya ozononidin intramuskuler ya da subkutan enjeksiyonu ozon salinimi ile ayni etkiyi gösterecektir tezine varilmaktadir. Ozonlanmis yag veya ozonidlerin intravenöz yolla verilmesi daha önce fare deneylerinde çalisilmis ve alveollerde kanama yaptigi görülmüstür. Ancak bulus konusu nano veya mikron boyutularda ozonlanmis yag içeren solüsyonlar ile yapilan çalismalarda farelere çok yüksek doz ozonlanmis yag veya ozonid subkutan (deri alti enjeksiyon) verilmis ve 3 gün üst üste yapilan 1mg/gr subcutan ozon uygulamasinin hiçbir ölüme sebep olmadigi aksine farelerde aktivite artisina neden oldugu gözlenmistir. Bu doz insanlara uygulanan bir tedavi dozu olan 3 mg ozonla karsilastirildiginda 70 kg'lik bir insan için 70000 mg ozon dozuna esittir. Bu da güvenlik araliginin çok yüksek oldugu ve ozon dozlarinin aslinda çok daha yüksek oranlarda kullanilabilecegi gerçegini ortaya koymaktadir. Ozonidlerin yogun bir yag solüsyonu olmasi bir avantaj saglamaktadir. Yogun yaglarin cilt alti ve intramusculer uygulamalari yagin içindeki ilaçlarin yavas salgilanmasini saglayarak uzun salinimli ilaçlar olusturmaktadir. Bupivakainin yag içinde enjeksiyonu 72 saat lokal etki saglamaktadir. In long ozonation processes, the oils before and after the process are weighed with precision scales. 160 mg/g in vegetable oils when weighed; in hydrocarbon oils at a concentration of 120mg/gr Ozone formation is observed, which is good for measuring the amount of ozone in oil. and creates a safe measurement method. Also in injection applications Calculations are made in micrograms. For example, a major therapy In the session, 100 ml (cc) of ozone with a density of 30 micrograms is applied, that is, in total. 3 mg of ozone is given as a mixture with oxygen. Approximate in local applications same doses are used. The same doses of ozonized oil or ozononidine Intramuscular or subcutaneous injection will have the same effect as ozone release. the thesis is reached. Intravenous administration of ozonated oil or ozonides is more It has been studied in mouse experiments before and it has been seen that it bleeds in the alveoli. However with solutions containing ozonized oil in nano or micron sizes. In studies, very high doses of ozonized oil or ozonide were administered subcutaneously to mice. 1mg/gr subcutaneous ozone given (subcutaneous injection) and administered 3 consecutive days application did not cause any death, on the contrary, it caused an increase in activity in mice. has been observed. This dose is combined with a therapeutic dose of 3 mg ozone administered to humans. In comparison, it is equivalent to a dose of 70000 mg of ozone for a 70 kg person. This is security range is very high and ozone doses are actually much higher reveals the fact that it can be used. A concentrated oil solution of ozonides it provides an advantage. Subcutaneous and intramuscular applications of dense oils long-release drugs by slow release of the drugs in the oil forms. Injection of bupivacaine in oil provides a local effect for 72 hours.
Ozonlanmis yag veya ozonidle kombine edildiginde hem bölgesel enjeksiyon agrisini azaltabilecek hem de bölgesel uzun süreli ozon salinimi sayesinde yüksek doz ozonun uzun süreli antioksidan etkisinden yararlanilacaktir. Ozellikle ameliyat sonrasi agri ve enfeksiyonun giderilmesi, antiinflamatuar etkinin saglanmasi amaciyla operasyon bitiminde bölgesel enjeksiyon yapilmasi hem yara iyilesmesini hizlandirmakta hem de bölgesel agriyi azaltmakta ve enfeksiyonun olusmasini engellemektedir. Agri kesici lokal anesteziklerle birlikte kullanilirsa ameliyat sonrasi agrilari azaltmaktadir. Eklem içi ozon uygulamalari içinde ayni etki söz konusudur. 1 ml ozonlanmis yag veya ozonidde yaklasik 100 mg ozon oldugu göz önüne alindiginda 0.1 ml yagda ozon dozu yaklasik 1 mg'dir. Normalde ozon cihaziyla yapilan ozon/oksijen karisimi gaz halinde eklem içine 20 mikrogram ozon 20 ml (cc) verilmektedir. 400 mikrogram ozon dozunun 2,5 kati bu kadar az miktarda yag ile verilmektedir. Ozonlanmis yag veya ozonidlerdeki ozon miktarinin gram olarak ölçülmesiyle birlikte yaglarla etkilesime girdiginde yaglarin doymus yaglar olmasini sagladigi ve yapisinin degistigi de bilinmektedir. Etki mekanizmasinin uygulandigi bölgeyi oksitleyerek dokuda bir tahribat olusturdugu ve buna bagli vücudumuzun tamir mekanizmasini aktive ettigi söylenmektedir. Yaglarin ozonlanmasi sonucu ozonun 02 ve 0' seklinde karbonlar arasinda baglandigi dokuya her ikisinin de transfer edildigi bilinmektedir. Yüksek dozlarda dokuyu okside ederek doku hasari olusturmaktadir. When combined with ozonated oil or ozonide, it relieves both local injection pain. high-dose ozone, thanks to the regional long-term ozone release, which can reduce long-term antioxidant effect will be benefited. Especially postoperative pain and operation to remove the infection, to provide the anti-inflammatory effect Regional injection at the end of the day both accelerates the wound healing and It reduces regional pain and prevents the occurrence of infection. Painkiller If used with local anesthetics, it reduces post-operative pain. intra-articular The same effect is in question in ozone applications. Consider that there is approximately 100 mg of ozone in 1 ml of ozonized oil or ozonide. When taken, the ozone dose in 0.1 ml oil is approximately 1 mg. Normally done with ozone device ozone/oxygen mixture gaseous intraarticular 20 microgram ozone 20 ml (cc) are given. With such a small amount of oil, 2.5 times the dose of 400 microgram ozone are given. The amount of ozone in the ozonized oil or ozonides in grams. With the measurement of fats, when interacting with fats, it is necessary to ensure that fats are saturated It is also known that it provides and its structure changes. The mechanism of action is applied that it oxidizes the area and causes damage to the tissue and accordingly, our body repairs it. It is said to activate the mechanism. As a result of ozonation of oils, ozone 02 and 0' shaped carbons, both of which are transferred to the tissue where it is bonded. known. In high doses, it oxidizes the tissue and causes tissue damage.
Düsük dozlarda yaglardan yavas salinarak dokuya hem oksijen salinimi yapmakta hem de serbest oksijen salgilamaktadir. Bu durum doku iyilestirici özelligini ve serbest radikallerin baglanmasini saglamaktadir. Yara tedavilerinde görülen iyilesme mekanizmasi ve cilt kremlerinde görülen reaksiyonlar dokulara oksijen tasinmasinin arttigi yönündedir. Cilt üzerine uygulandiginda bile cilt alti dokulara emilen oksijen miktarinin arttigi ve cildin renginde açilma oldugu görülmektedir. Yara bölgesinde hem oksidasyon etkisiyle yara bölgesini aktive ettigi ve tamir mekanizmasini aktive ettigi hem de ozonlanmis yag veya ozonid içindeki serbest oksijenin dokuya aktarilmasi sonucu dokunun oksijenlenmesini arttirdigi görülmektedir. Antibakterial, antivirütik, antifungal özellikleri ve antienflamatuar, analjezik etkileri de diger yara iyilestirici etkileridir. Bu tüm etkiler nasil yüzeysel uygulamalarda aktive oluyorsa bölgesel enjeksiyon uygulamalarinda da aktive olacagi düsünülmektedir. Fare çalismalarinda subkutan enjeksiyonla 1 mg/gr gibi çok yüksek dozda yapilan cilt alti enjeksiyonlarin farelerin ölümüne sebep olmadigi ancak bölgesel olarak cilt nekrozu yaptigi bölgesel tüy dökülmesi ve yara olusturdugu görülmektedir. Bu dozun insanlara uygulanan bölgesel enjeksiyon dozunun 70000 kat fazlasi oldugu düsünüldügünde 70 kgilik bir kisiye 70 gr ozon enjeksiyonunun ayni bölgeye 3 gün üst üste yapilmasi anlamina gelmektedir. Bu dozlarin kullanimiyla fareler 1 ay süreyle izlenmis ve ölüme rastlanmamistir. Ozonlanmis yag veya ozonidlerin yogun olmasi enjeksiyon yapilmasini zor hale getirerek bölgesel kizarikliga ve nekrozlara sebep olabilmektedir. In low doses, it releases slowly from fats and releases oxygen to the tissue. It also releases free oxygen. This situation has tissue healing properties and free It ensures the binding of radicals. Improvement in wound treatments mechanism and reactions seen in skin creams is in the direction of increasing. Oxygen absorbed into subcutaneous tissues even when applied on the skin It is seen that the amount of the skin increases and there is a lightening in the color of the skin. in the wound area It activates the wound area with its oxidation effect and activates the repair mechanism. as well as the transfer of free oxygen in the ozonized oil or ozonide to the tissue As a result, it is seen that it increases the oxygenation of the tissue. antibacterial, antiviral, antifungal properties and anti-inflammatory, analgesic effects are also other wound-healing effects. Just as all these effects are activated in superficial applications, regional It is thought that it will also be activated in injection applications. in mouse studies Subcutaneous injections made at a very high dose such as 1 mg/gr by subcutaneous injection It did not cause the death of the mice but locally caused skin necrosis. It is seen that hair loss and wound formation. This dose is administered to humans. Considering that the regional injection dose is 70000 times more, a 70 kg It means that 70 gr ozone injection is done to the same area for 3 consecutive days. is coming. With the use of these doses, the mice were followed for 1 month and died. not found. Concentration of ozonized oil or ozonides It can cause regional redness and necrosis by making it difficult to do.
Bu nedenle hazirlanan sudaki yag emülsiyonlari bir diger uygulama biçimidir. Birçok farkli yöntemle (utrasonik yag parçalama cihazlari, nanoteknolojik yöntemler vb.) ozonlanmis yag veya ozonidler su içinde çözülerek ozonlanmis yag veya ozonid içeren solüsyonlar haline getirilmektedir. Mikroskobik incelemede 1 nanometreden - 400 mikrona kadar genis bir aralikta su içinde asili nano veya mikron partikül boyutuna sahip ozonlanmis yag veya ozonidler gözlenmektedir. Bu solüsyonlar istege bagli olarak %1 den %90 a kadar degisen oranlarda hazirlanabilir. For this reason, oil-in-water emulsions are another form of application. Many with different methods (utrasonic fat breakdown devices, nanotechnological methods, etc.) ozonized oil or ozonides dissolved in water containing ozonized oil or ozonide are made into solutions. From 1 nanometer to 400 in microscopic examination to nano or micron particle size suspended in water in a wide range down to micron Ozonated oil or ozonides are observed. These solutions are optional It can be prepared in varying proportions from 1% to 90%.
Yag emülsiyonlari (solüsyonlari) olusturmak üzere kullanilan emülgat'orler damar içi beslenme solüsyonlari olusturmak için yillardir basariyla kullanilmaktadir. Yumurta sarisindan olusturulan Iesitin, Iisofosfolipid (12), polietilen glikol (PEG), fosfatidiletanolaminin (PEG-PE), pluronik, polisorbat 20, polisorbat 80 gibi emülgatörler uygulamasi yapilmis piyasaya sunulmus ürünler içinde bulunmaktadir. Bunlar güvenle kullanilan emülgat'orlerdir. Insan ve hayvan sagliginda bu ajanlardan biri ya da birkaçi kullanilirken diger sekt'orler için genel kullanim amaçli emülgatorler de kullanilabilir. Emulsifiers used to form oil emulsions (solutions) intravenously It has been used successfully for many years to create nutritional solutions. Egg Iecithin, Iisophospholipid (12), polyethylene glycol (PEG), formed from the yolk emulsifiers such as phosphatidylethanolamine (PEG-PE), pluronic, polysorbate 20, polysorbate 80 It is included in the products that have been applied to the market. These are safely used emulsifiers. One or more of these agents in human and animal health While being used, emulsifiers for general use can also be used for other sectors.
Nano veya mikron boyutlarda yag partiküllerin olusturulmasi farkli metotlar ile yapilabilmektedir. Bulus konusu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar tercihen iki sekilde yapilabilmektedir. Her iki sekilde de tercihen 'önce uygulamanin yapilacagi yag ya da yag karisimlari ozonlanip daha sonra nano veya mikron partikül olusturma ve emülsiyon islemi yapilabilmektedir. Fakat önce nano veya mikron partiküller olusturulup daha sonra ozonlama islemi de yapilabilir. Bu durumda partikül büyüklügü artmaktadir. The formation of oil particles in nano or micron sizes can be done by different methods. can be done. The subject of the invention contains ozonized oil in nano or micron sizes. The solutions can preferably be made in two ways. Either way, preferably 'before The oil or oil mixtures where the application will be made are ozonized and then nano or micron particle formation and emulsion process can be done. But first nano or Micron particles can be formed and then ozonation can be done. In this case particle size increases.
Bulus konusu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin üretim metodu; A. Yaglarin ozonlanmasi, B. Distile suyun en az bir emülgat'or ile karistirilmasi, C. Ozonlanmis yaglarin distile su ve en az bir emülgatör içeren karisima eklenmesi ve kesici biçaklar içeren karistirici ile karistirilmasi, D. Olusan solüsyonun püskürtülerek sogutulmasi, E. Ultrasonik parçalama y'ontemleri kullanilarak ozonlanmis yag içeren solüsyonun partikül boyutlarinin 1 nanometreye kadar küçültülmesi, A islem adiminda kullanilan yaglar tercihen enjekte edilebilir özellikteki yaglardir. The subject of the invention is the production of solutions containing ozonized oil in nano or micron sizes. method; A. Ozonation of oils, B. Mixing distilled water with at least one emulsifier, C. A mixture of ozonized oils with distilled water and at least one emulsifier adding and mixing with a mixer containing cutting blades, D. Cooling the resulting solution by spraying, E. Containing oil that has been ozonized using ultrasonic fractionation methods reducing the particle size of the solution down to 1 nanometer, The oils used in the A process step are preferably injectable oils.
Bulusun tercih edilen uygulamalarinda soya yagi, susam yagi, palmiye yagi, hashas yagi, soya Iesitin, kolesterol, b-sterol, trigliserid, zeytin yagi, balik yagi, ayçiçek yagi, hint yagi, safran yagi (safflower), hindistan cevizi yagi, trigliserid türevleri, tributirin, tricaproin, tricaprylin gibi bitkisel ve hayvansal yaglar ya da parafin (mineral oil), etil oleat, metil oleat gibi kimyasal kökenli (hidrokarbon türevi) yaglar kullanilmaktadir. In preferred embodiments of the invention, soybean oil, sesame oil, palm oil, hash oil, soybean oil, cholesterol, b-sterol, triglyceride, olive oil, fish oil, sunflower oil, castor oil, safflower oil (safflower), coconut oil, triglyceride derivatives, tributyrin, vegetable and animal oils such as tricaproin, tricaprylin or paraffin (mineral oil), ethyl Chemical origin (hydrocarbon derivative) oils such as oleate, methyl oleate are used.
Bulus konusu solüsyonlarin hazirlanmasinda tek bir çesit yag kullanilabilecegi gibi farkli yaglar içeren bir yag karisimi da kullanilabilmektedir. A islem adiminda yaglar tercihen 10 gün boyunca ozonlama islemine tabi tutulmaktadir. Ozonlama isleminin süresi kullanilan yagin türü ve kalitesi ve kullanim alanina göre degismektedir. A single type of oil can be used in the preparation of the inventive solutions. An oil mixture containing different oils can also be used. oils in step A preferably it is subjected to ozonation process for 10 days. Ozonation process The duration varies according to the type and quality of the oil used and the area of use.
Ozonlama isleminde ozon kaynagi olarak ozon jeneratörleri kullanilmaktadir. Bu cihazlardan elde edilen ozon/oksijen karisimi ile ozonlama islemi yapilmaktadir. Yag içindeki ozon miktari A islem adimindan önce ve sonra ozonlama islemine tabi tutulan yagin kütlesi ölçülerek tespit edilebilmektedir. Olçüm islemi için hassas terazi kullanilmaktadir. Böylece yag içerisindeki ozon miktari miligram cinsinden belirlenmis olmaktadir. In ozonation process, ozone generators are used as ozone source. This The ozonation process is carried out with the ozone/oxygen mixture obtained from the devices. Oil The amount of ozone in the ozone treated before and after the A treatment step. It can be determined by measuring the mass of oil. Precision balance for measuring is used. Thus, the amount of ozone in the oil was determined in milligrams. is happening.
Ozonlama islemi ozon cihazinin yogunlugunu göre degismektedir. Ornegin; saatte 100 gram ozon çikisi olan sanayi tipi ozon jeneratör'üyle 'önce yag gram cinsinden ölçülmektedir. 3 - 4 saat sonra %10 oraninda ozonlanmis yag elde edilmektedir. Bu sekilde 10 kg yag 11 kg olmaktadir. Bu durum yagin cinsine göre degismektedir. The ozonation process varies according to the density of the ozone device. For example; 100 per hour With the industrial type ozone generator with gram ozone output, 'oil first in grams' being measured. After 3 - 4 hours, 10% ozonated oil is obtained. This In this way, 10 kg of fat becomes 11 kg. This situation varies according to the type of oil.
Ozonlama cihaz hacmi küçültülür ve yag hacmi arttirilirsa ozonlama islem süresi uzamaktadir. Genellikle %10 'üzerinde ozonlama islemi uzun sürmektedir. If the ozonation device volume is reduced and the oil volume is increased, the ozonation process time is elongated. Generally over 10% ozonation process takes a long time.
Zamanla yagin ozon alma kapasitesi azalmaktadir. Böyle bir durumda yag ozonlama islemi devam ederken birkaç gün içinde doymus hale gelmekte ve donmaktadir. Over time, the ozone uptake capacity of oil decreases. In such a case, oil ozonation While the process continues, it becomes saturated and freezes within a few days.
Doymus yag eritilerek tekrar ozonlanma islemine tabi tutulabilmektedir. Bulusun bir gram artarak 1160 gr ozonlu zeytin yagina veya ozonide dönüsmektedir. Bu durum genellikle tüm bitkisel yaglarda geçerlidir. Parafin gibi hidrokarbon türevi yaglarda donma olmadigindan isitma islemi gerekmemektedir. Bulusun bir uygulamasinda, 1000 gr parafin tercihen 3 gün ozonlama islemine tabi tutuldugunda 1100 gr olmaktadir. Bu tür yaglarda zeytinyagi kadar ozonlama olusmamaktadir. Yüksek ozonlama islemi yagi asidik hale getirmektedir. Saturated fat can be melted and subjected to ozonation again. find one grams, it turns into 1160 g ozonated olive oil or ozonide. This situation generally applicable to all vegetable oils. In hydrocarbon derivative oils such as paraffin Heating is not required as there is no freezing. In one embodiment of the invention, 1000 g paraffin is preferably 1100 g when subjected to ozonation for 3 days. This Ozonation does not occur in such oils as much as olive oil. High ozonation process oil makes it acidic.
B islem adiminda distile su ve en az bir emülgatör içeren karisimin sicakligi kullanilan yagin cinsine göre yagin erime sicakliginin 10 - 15°C üzerinde olmaktadir. 8qu sun tercih edilen bir uygulamasinda, B islem adiminda distile su 70°C'ye kadar isitilmakta ve 'üzerine en az bir emülgat'or eklenmektedir. B islem adimi sonunda distile su ve emülgatörden olusan karisimin sicakligi 70°C olmaktadir. B islem adiminda su ve emülgatör tercihen 11000 rpm'de 5 dk. karistirilmaktadir. Yumurta sarisindan olusturulan Iesitin, Iisofosfolipid, polietilen glikol (PEG), fosfatidiletanolaminin (PEG- PE), pluronik, polisorbat 20, polisorbat 80 gibi emülgatörler veya farkli maddeler de emülgatör olarak kullanilabilmektedir. Bulusun tercih edilen bir uygulamasinda emülgatör olarak polisorbat 80 kullanilmaktadir. Emülgatör sayesinde su ve yagin birbiri içinde karismasi saglanmaktadir. In process step B, the temperature of the mixture containing distilled water and at least one emulsifier is used. According to the type of oil, it is 10 - 15°C above the melting temperature of the oil. 8qu sun In a preferred embodiment, in process step B, distilled water is heated up to 70°C. and at least one emulsifier is added. At the end of process step B, distilled water and The temperature of the mixture consisting of the emulsifier is 70°C. In process step B, water and emulsifier preferably at 11000 rpm for 5 min. are mixed. from egg yolk Iecithin, Iisophospholipid, polyethylene glycol (PEG), phosphatidylethanolamine (PEG- emulsifiers such as PE), pluronic, polysorbate 20, polysorbate 80, or other substances. can be used as an emulsifier. In a preferred embodiment of the invention Polysorbate 80 is used as emulsifier. Thanks to the emulsifier, water and oil are provided to mix with each other.
C islem adiminda distile su, en az bir emülgatör ve ozonlanmis yag içeren karisimin sicakligi kullanilan yagin cinsine göre yagin erime sicakliginin 10 - 15“C üzerinde olmaktadir. Bulusun tercih edilen bir uygulamasinda, C islem adiminda 70°C sicakliktaki distile su ve emülgatör karisimi üzerine yine ?OC sicakliktaki ozonlanmi s yag (veya ozonid) eklenmektedir. Olusan karisim kesici biçaklar içeren karistirici cihaz ile yüksek devir hizinda karistirilmaktadir. Bulusun tercih edilen bir uygulamasinda yapilmaktadir. Böylece 1 nanometre - 400 mikrometre boyutlarinda parçalanmis ozonlanmis yag (veya ozonid) içeren solüsyonlar hazirlanmaktadir. In process step C, the mixture containing distilled water, at least one emulsifier and ozonized oil Its temperature is 10 - 15“C above the melting temperature of the oil, depending on the type of oil used. is happening. In a preferred embodiment of the invention, process step C is at 70°C. On the mixture of distilled water and emulsifier at a temperature of ?OC, ozonated heat oil (or ozonide) is added. Mixer device with formed mix cutter blades It is mixed with at high rotation speed. In a preferred embodiment of the invention is being done. Thus, it was fragmented in 1 nanometer - 400 micrometer dimensions. Solutions containing ozonized oil (or ozonide) are prepared.
D islem adiminda distile su, en az bir emülgatör ve ozonlanmis yag (veya ozonid) içeren solüsyonlar püskürtme islemiyle sogutulmaktadir. Bu islem adiminda olusan solüsyon soguk bir alana püskürtülerek aniden sogumasi saglanmaktadir. In the process step, distilled water, at least one emulsifier and ozonized oil (or ozonide) The solutions containing it are cooled by spraying. If you occur in this action name The solution is sprayed onto a cold area, allowing it to cool suddenly.
Parçalanmis yagin uzun süre sicak bekletilmesi partikül büyümesine yol açmaktadir. Keeping the shredded oil warm for a long time leads to particle growth.
Bunu önlemek içi sogutma islemi yapilmaktadir. Sogutma islemi için tercihen soguk homojenizasyon cihazlari kullanilmaktadir. Bulusun tercih edilen bir uygulamasinda nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar 4°C veya daha dü sük sicakliklara kadar sogutulabilmektedir. Sogutma için belirli bir sicak araligi olmamakla beraber yüksek sicakliklar partikül büyümesine neden olabilmektedir. To prevent this, cooling is done. Preferably cold for cooling homogenization devices are used. In a preferred embodiment of the invention solutions containing ozonized oil in nano or micron sizes at 4°C or lower It can be cooled down to temperatures. Although there is no specific temperature range for cooling However, high temperatures can cause particle growth.
E islem adiminda ultrasonik parçalama yöntemleri kullanilarak ozonlanmis yag içeren solüsyonlarin partikül boyutu 1 nanometreye kadar küçültülmektedir. Ultrasonik parçalama yöntemleri, ultrasonik parçalayici cihaz veya reaktör vb. ekipmanlar ile gerçeklestirilmektedir. Bulusun tercih edilen bir uygulamasinda 10 - 50 nanometre araliginda partikül boyutlarina sahip ozonlanmis yag içeren solüsyonlar kullanilabilmektedir. Bulus konusu solüsyonlar 1 nanometre - 400 mikron araliginda ozonlanmis yag içermektedir. E-processing step containing ozonized oil using ultrasonic fractionation methods. The particle size of the solutions is reduced to 1 nanometer. Ultrasonic shredding methods, ultrasonic shredding device or reactor etc. with equipment is carried out. 10 - 50 nanometers in a preferred embodiment of the invention Solutions containing ozonized oil with particle sizes in the range can be used. The solutions of the invention are in the range of 1 nanometer - 400 microns. Contains ozonized oil.
Bulus konusu solüsyonlarin hazirlanmasinda kullanilacak yag öncelikle hassas terazi vasitasiyla tartilmakta ve sonuç kaydedilmektedir. Yag ozon jeneratöründen elde edilen ozon/oksijen karisimi ile ozonlama islemine tabi tutulmaktadir. Ozonlama isleminden sonra hassas terazi ile tekrar ölçüm yapilmakta ve yag içerisindeki ozon miktari miligram cinsinden elde edilmektedir. Daha sonra 70“C sicakliktaki distile su ve tercihen polisorbat 80 içeren karisim içerisine ayni sicakliktaki ozonlanmis yag (veya biçaklar içeren karistirici ile karistirilmaktadir. Olusan solüsyon 1 nanometre - 400 mikrometre boyutlarinda ozonlanmis yag (veya ozonid) partikülleri içermektedir. Bu solüsyon soguk bir alan püskürtülerek sogutulmaktadir. Son olarak hazirlanacak solüsyon istenilen form, içerik ve miktara göre ambalajlanmaktadir. The oil to be used in the preparation of the inventive solutions must first be weighed on a precision balance. It is weighed and the result is recorded. Obtained from Yag ozone generator It is subjected to ozonation process with ozone/oxygen mixture. From the ozonation process Then the measurement is made again with a precision scale and the ozone amount in the oil is determined. obtained in milligrams. Then distilled water at 70°C and Ozonated oil (or oil) at the same temperature into the mixture preferably containing polysorbate 80. mixed with a mixer containing blades. The resulting solution 1 nanometer - 400 It contains ozonized oil (or ozonide) particles in micrometer size. This the solution is cooled by spraying a cold area. Finally to be prepared The solution is packaged according to the desired form, content and amount.
Yukarida anlatilan üretim metodunda sicak homojenizasyon yapilacaksa suyun 70°C'de %2 - 5 oranlarinda tercihen polisorbat 80 ile karistirilmasi sonrasi yagin erime karistirilmasi sonucu olusturulan nano veya mikron boyuttaki partiküllerin hizla soguk ortama püskürtülmesiyle elde edilen stabil nano veya mikron boyuttaki partiküllerin ozonlanmasi da alternatif bir yöntemdir. Ancak sicak ortam ozonidlerin çözünmesine neden olabilir ve yagin içindeki ozon dozlarini azaltabilir. Sicak homojenizasyonun etkilerinden kurtulmak için soguk homojenizasyon yöntemiyle de nano partikül olusturmak mümkündür. Uygulamanin yapilacagi alana göre partikül büyüklügü ayarlanabilir. Sicak ya da soguk homojenizasyon ile olusturulmus nano veya mikro partiküllerin ultrasonik yöntemle yeniden parçalanmasi daha küçük partiküllerin olusumunu saglamaktadir. If hot homogenization is to be made in the production method described above, the water Melting of the oil after mixing preferably with polysorbate 80 at a rate of 2 - 5% at 70°C. nano or micron sized particles formed as a result of mixing Stable nano- or micron-sized particles obtained by spraying into the environment ozonation is also an alternative method. However, the hot environment causes the ozonides to dissolve. and may reduce ozone doses in the oil. Hot homogenization nanoparticles can be used with cold homogenization method to get rid of the effects of possible to create. Particle size according to the application area adjustable. Nano or micro produced by hot or cold homogenization re-fragmentation of particles by ultrasonic method into smaller particles provides its formation.
Bulus konusu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar ultrasonik yöntemler ile de üretilebilmektedir. Bu yöntemlerde utrasonik yag parçalayici cihazlar kullanilmaktadir. Ultrasonik yöntemle yaglarin parçalanarak nano veya mikron boyutunda partikül olusturulmasinda isil islem kullanilmamaktadir. Uygulama esnasinda sogutma islemi uygulanabilir. Bu yöntemde emülgatör kullanmaya gerek yoktur. Çünkü 1 mikrondan küçük partiküller olusturulabilmektedir. Uygulama süresi arttikça partikül büyüklügü küçülmektedir. Bu yöntemle 1 nanometreden 400 mikrometreye kadar küçültülebilen yag partikülleri olusturulabilir. Solutions containing ozonized oil in nano or micron sizes, which are the subject of the invention It can also be produced by ultrasonic methods. In these methods, ultrasonic fat splitter devices are used. By breaking down the oils by ultrasonic method, nano or micron Heat treatment is not used in the formation of particles in size. Application During the cooling process can be applied. No need to use emulsifier in this method. there is none. Because particles smaller than 1 micron can be formed. Application time increases, the particle size decreases. With this method, from 1 nanometer to 400 Oil particles that can be reduced to micrometers can be formed.
Bir üçüncü üretim metodu olarak Zeta potansiyel yöntemiyle de nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin olusturulmasi mümkündür. Bu yöntemde elektroliz islemi kullanilmaktadir. Stabil solüsyonlar için 25 mV uygulamalar uygun bulunmaktadir. Nano veya mikro boyutlarda ozonlanmis yag veya ozonidlerin olusturulmasi doz ayarlamanin yapilabilmesi ve seyreltik solüsyonlar olusturarak ozonun daha güvenli kullanilmasini saglamaktadir. Yaglarin enjeksiyonunda olusan emilim bozukluklari yagin dokuda kalmasi ve apse enfeksiyon olusturmasi gibi sorunlar nano veya mikro partiküller sayesinde ortadan kalkmaktadir. Ornegin; içinde 1 mg ozon bulunan 1 ml den 5 ml ye kadar solüsyon hazirlamak mümkündür. Böylece eklem içi gibi bölgelere enjeksiyon yapmak kolaylasmaktadir. Ayni zamanda doku içinde yogunluguna göre kalma süresi hesaplanarak diger ilaçlarin uzun etkili olarak ozonla birlikte dokuya enjekte edilmesi saglanabilmektedir. Bu durum en iyi lokal anesteziklerle anlasilabilir. Normalde enjeksiyon bölgesinde 2 saat kadar etkili olan ilaçlarinda bölgesel etkilesimleri ve sistemik ilaçlarin salinim süreleri hesaplanabilir. As a third production method, with the Zeta potential method, nano or micron It is possible to create solutions containing ozonized oil in different sizes. This Electrolysis process is used in the method. 25 mV applications for stable solutions are available. Ozonated oil or ozonides in nano or micro sizes by creating dilute solutions so that dose adjustment can be made It ensures safer use of ozone. Formed in the injection of oils Problems such as absorption disorders, fat remaining in the tissue and abscess infection It disappears thanks to nano or micro particles. For example; 1 mg of ozone in It is possible to prepare a solution from 1 ml to 5 ml. Thus, the intra-articular It is easier to inject into areas such as Also in tissue By calculating the residence time according to the concentration, the long-acting ozone treatment of other drugs. It can be injected into the tissue together. This is the best local understandable with anesthetics. It is normally effective for up to 2 hours at the injection site. Regional interactions of drugs and release times of systemic drugs can be calculated.
Ozellikle cilt alti dokulara ozonlanmis yag veya ozonid uygulamasinin yogun dozlarda olmamasi seyreltik solüsyonlar halinde olmasi önemlidir. Cilt alti doku nekrozu olmamasi için solüsyonlarin %1 - 10 oraninda ozonlanmis yag veya ozonid içeren sudaki solüsyonlari tercih edilmektedir. Derin dokulara kas ve yag içi dokulara uygulamalarda daha yogun dozlara çikilmasi uygundur. Ancak bir bölgesel enjeksiyon dozunun 3 - 5 mg ozon dozu oldugu düsünülürse içinde %5 ozon bulunan solüsyonun 1 ml'si ile uygulama rahatlikla yapilabilmektedir. Yara tedavilerinde içinde 160 mg/gr ozon içeren ozonlanmis yag veya ozonidle bölgesel olarak 10 - 15 gr krem kullanilmaktadir. Bu yogun ozon dozunun yara tedavisinde daha etkili oldugu düsük doz ozon içeren kremlerin yarayi çabuk tedavi etmedigi yapilan çalismalarda gözlenmistir. Bunlar dikkate alinacak olursa seyreltik dozlar olmak kosuluyla bölgesel enjeksiyonlarda çok daha yüksek dozda ozonun verilmesi gerektigi düsünülmektedir. Intense doses of ozonized oil or ozonide application especially to subcutaneous tissues. It is important that it is not in the form of dilute solutions. Subcutaneous tissue necrosis 1 - 10% of solutions containing ozonized oil or ozonide to prevent Solutions in water are preferred. To deep tissues, muscle and fat tissues In applications, it is appropriate to increase to more intense doses. However, a local injection If the dose is thought to be 3 - 5 mg ozone, the solution containing 5% ozone should be Application can be done easily with 1 ml. 160 mg/gr in wound treatments 10 - 15 g cream locally with ozonized oil containing ozone or ozonide is used. It is low that this intense dose of ozone is more effective in wound treatment. In the studies carried out in which the creams containing dose ozone did not heal the wound quickly, has been observed. If these are taken into account, the regional It is thought that a much higher dose of ozone should be given in injections.
Bu amaçla hazirlanmis ozonlanmis yag veya ozonidlerin sudaki solüsyonlari doz ayarlamasinda bölgeye göre degisebilen oranlarda uygulama ile kolaylik saglamaktadir. Ayni zamanda nano veya mikron boyuttaki partiküllerin olusturulmasi sayesinde bölgesel emilimi kolaylastirdigi için doku nekrozu ve alerjik reaksiyonlar yapmadan bölgeden emilmesini saglamaktadir. For this purpose, ozonized oil or ozonides solutions in water are dosed. Ease of application with varying rates depending on the region. it provides. At the same time, the formation of particles of nano or micron size tissue necrosis and allergic reactions as it facilitates local absorption It ensures that it is absorbed from the area without making it.
Hem ozonlanmis yag veya ozoniddeki ozon dozu ayarlanarak hem de sudaki solüsyondaki yogunluk ayarlanarak çok seyreltik ozon solüsyonlari hazirlanabilir. Both by adjusting the ozone dose in ozonized oil or ozonide and by Very dilute ozone solutions can be prepared by adjusting the concentration in the solution.
Yogun ozonlanmis yag veya ozonidlerin enjeksiyonunda az miktarda yag içinde çok miktarda ozon oldugu düsünülmektedir. Enjeksiyonda ne kadar az yag kullanilirsa yagin yan etkisi o oranda az olmaktadir. Bu yüzden yüksek ozonlu yaglarin sudaki solüsyonlari avantaj saglamaktadir. In the injection of densely ozonized oil or ozonides, a small amount of oil in a very amount of ozone is considered. The less oil used in the injection The side effects of the oil are less at that rate. Therefore, the high ozone oils in the water solutions are advantageous.
Nano veya mikron boyutlarda parçalanmis ozonlanmis yag içeren solüsyonlar doz ayarlamasi yapilabilmekte ve seyreltik solüsyonlar hazirlanabilmektedir. Böylece ozon daha güvenli bir sekilde kullanilmaktadir. Hazirlanan nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar kullanim bölgelerine ve kullanilan aparatlara göre degisen dozlarda hazirlanmaktadir. Solutions containing ozonized oil fragmented in nano or micron sizes. can be adjusted and diluted solutions can be prepared. So ozone used in a safer way. Prepared in nano or micron sizes Solutions containing ozonized oil are used according to the areas of use and the apparatus used. It is prepared in varying doses.
Bulus konusu solüsyonlar fitil formunda kullanilacak ise witepsol vb. maddeler eklenerek olusan karisim sogutulmaktadir. If the inventive solutions are to be used in the form of suppositories, witepsol etc. substances The mixture formed by adding water is cooled.
Bulus konusu ozonlanmis yag içeren solüsyonlar insülin veya lokal anestezik ilaçlar gibi ilaçlar ile kombine edildiginde bu ilaçlarin salinim ve etki sürelerini uzatmakta ve emilimlerini kolaylastirmaktadir. The subject of the invention is solutions containing ozonized oil, insulin or local anesthetic drugs. When combined with drugs such as facilitates their absorption.
Bölgesel enfeksiyonlarda bulus konusu ozonlanmis yag içeren solüsyonlarinin enjeksiyonu yavas salinim yapacagindan oksijenlenmeyi arttirmaktadir ve antibiyotik kullanimini azaltmaktadir. Apse içine ve çevresine enjeksiyon seklinde uygulanabilmektedir. Ameliyat yara iyilesmesini arttirmak amaciyla ameliyat bölgesine enjekte edilebilmektedir. In regional infections, solutions containing ozonized oil, which is the subject of the invention, Since the injection will release slowly, it increases oxygenation and antibiotic reduces its use. Injection into and around the abscess applicable. In order to increase the surgical wound healing, the surgical area can be injected.
Venöz kanin 5 - 10 mlilik (cc) miktariyla bulus konusu ozonlanmis yag içeren solüsyonunun karistirilarak intramuskuler enjeksiyonu minör terapi olarak bilinen tedavi yöntemine esdegerdir. 5 - 10 ml (cc) of venous blood, the subject of the invention, containing ozonized oil mixed intramuscular injection of a solution known as minor therapy is equivalent to the method.
Bahsedilen ozonlanmis yag içeren solüsyonlar tüm harici formlar ve mukozal formlarda gümüs nano partikülleriyle birlikte kullanilabilmektedir. Bulusu konusu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar gümüs ve benzeri oligodinamik etki gösteren metaller ile kombine edilerek kullanilabilmektedir. The solutions containing the aforementioned ozonized oil are available in all external forms and mucosal forms. It can be used with silver nanoparticles. The subject of the invention is nano or solutions containing ozonized oil in micron sizes, silver and similar oligodynamic It can be used in combination with metals that are effective.
Kozmetik amaçli ürünlerde ozonlanmis yag içeren solüsyonlar hyaluronik asit ve yagda eriyen vitaminler ile kombine edilebilmektedir. In cosmetic products, solutions containing ozonized oil are used in hyaluronic acid and oil. It can be combined with soluble vitamins.
Ortopedide Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Bölgesel agrilarin nedeni bilindigi gibi kas spazmina bagli doku oksijenlenmesindeki azalma ve buna bagli enflamasyonun artmasidir. Bölgesel ozon uygulamalarinda agri bölgesine yüzeysel ve derin olmak üzere ozon/oksijen gazi verilmektedir. 20 mikrogram ozon gazi 40 - 50 ml (cc) bölgesel olarak enjekte edilerek antiinflamatuar analjezik etki saglanmaktadir. Ayni zamanda doku oksijenlenmesi arttigindan kas gevsetici etkiler elde edilmektedir. Subkutan ve kas içi ozonlanmis yag veya ozonid uygulamasi ile bölgesel suda çözünmüs nano veya mikron boyutlarda ozon yagi enjekte edilebilmektedir. Ozellikle parafin yaginin enjeksiyonda kas gevsetici özelligi oldugu bilinmektedir. Ozon yogunlugu bölgesel uygulamalarda 1 - 2 mg dozda kullanilirken yaglarda ozonun çözünmesi 72 saate kadar uzadigi için 5 - 6 mg dozlara çikilabilir. Bu uygulama ayni bölgeye haftada bir en çok iki kez yapilabilmektedir. Uygulanacak solüsyona tercihen lokal anestezik Iidokain ya da bupivakain, antienflamatuar ajanlar eklenebilir. Use of Ozonated Oil-Containing Solutions in Orthopedics As the cause of regional pains is known, tissue oxygenation due to muscle spasm decrease and the associated increase in inflammation. Pain in regional ozone applications ozone/oxygen gas is given to the region as superficial and deep. 20 micrograms Anti-inflammatory analgesic effect by injecting ozone gas 40 - 50 ml (cc) locally is provided. At the same time, muscle relaxant effects due to increased tissue oxygenation is obtained. With subcutaneous and intramuscular ozonated oil or ozonide administration Injecting ozone oil in nano or micron sizes dissolved in regional water can be achieved. In particular, paraffin oil has a muscle-relaxing feature in injection. known. While ozone concentration is used at a dose of 1 - 2 mg in regional applications. Since the dissolution of ozone in oils takes up to 72 hours, doses of 5-6 mg can be increased. This The application can be made to the same area once a week, at most twice a week. to be applied solution preferably local anesthetic Iidocaine or bupivacaine, anti-inflammatory agents can be added.
Ozon gazi enjeksiyonunda kisa süreli yanma ve kasinti olabilmektedir. Ancak kas içi enjeksiyonlarda bu etki pek görülmemektedir. Bu nedenle özellikle yüzeysel enjeksiyon yapilacaksa lokal anestezik içeren ozonid solüsyonlari tercih edilmelidir. Eklem içi enjeksiyonlarda ozonun etkisi son yillarda iyice ortaya konulmaktadir. Eklem kikirdaginin oksijenlenmesini arttirarak kikirdak kaybini önledigi, antiinflamatuar etkiyle analjezik etkisi sayesinde agriyi azalttigi bilinmektedir. Literatürde bununla ilgili pek çok yayin bulunmaktadir. Kendi yaptigimiz arastirmalarda da benzer sonuçlarla 100 hastanin 187 dizine 8 seans ozon 2 seans prp tedavisi uygulamasi sonucu VAS skorlarinin ortalama 8,5'den 4'e düstügü gözlemlenmistir. Bu uygulamalarda 20 mikrogram ozon 20 ml (cc) olarak verilmistir. Yani 400 mikrogram ozon uygulanmistir. In ozone gas injection, there may be short-term burning and itching. However, intramuscular This effect is not seen much in injections. For this reason, especially superficial injection If it is to be done, ozonide solutions containing local anesthetics should be preferred. intra-articular The effect of ozone in injections has been well demonstrated in recent years. Joint It prevents the loss of cartilage by increasing the oxygenation of the cartilage, has an anti-inflammatory effect. It is known to reduce pain thanks to its analgesic effect. In the literature, there are many There is a broadcast. Similar results were found in our own research. VAS as a result of 8 sessions of ozone 2 sessions of prp treatment on 187 knees of the patient It was observed that the average scores of the students decreased from 8.5 to 4. 20 in these applications microgram ozone is given as 20 ml (cc). In other words, 400 micrograms of ozone was applied.
Ayni uygulama için suda seyreltilmis nano veya mikron boyutlarda ozonlanmis yag veya ozonidlerin çözünmesi 72 saat kadar sürecegi için 1 - 2 mg dozda kullanilabilir. For the same application, ozonized oil diluted in water in nano or micron sizes or it can be used at a dose of 1 - 2 mg, as it will take up to 72 hours for the ozonides to dissolve.
Haftada bir en çok iki kez uygulanabilir. Bunlara ek olarak lokal anestezik ve antiinflamatuar ajanlarla kombine edilebilir. Son yillarda deneysel çalismalari artan E vitamini yag çözeltisi ve antiinflamatuar ilaçlarla birlikte uygulanabilir. Hyaluronik asidin eklem içi enjeksiyonda kikirdak matriksini arttirici etkisi bilinmektedir. Yapilan ozon tedavisi ve hyaluronik asit kombinasyonlari ile daha iyi sonuçlar alindigi bilinmektedir. It can be applied once or twice a week. In addition, local anesthetic and It can be combined with anti-inflammatory agents. In recent years, experimental studies have increased. It can be applied together with vitamin oil solution and anti-inflammatory drugs. hyaluronic acid It is known to increase the cartilage matrix in intra-articular injection. ozone made It is known that better results are obtained with treatment and hyaluronic acid combinations.
Bulus ile ilgili yapilan çalismalarda ozonlanmis yag veya ozonidlerin sudaki çözeltilerini solüsyonun eklem içinde kullanimi kikirdak iyilesmesindeki etkiyi arttirmaktadir. In the studies related to the invention, ozonized oil or ozonides solutions in water. The use of the solution in the joint increases the effect on cartilage healing.
Bel fitigi, boyun fitigi sik karsilasilan saglik sorunlarindandir. Yaptigimiz çalismada 66 bel fitigi tanisi almis hastaya 8 seans ozon 2 seans prp uygulamalarinda bölgesel enjeksiyonlardan 1 ay sonra 4 ay sonra ve 1 sene sonra VAS skorlamasina göre agri skoru bakilmistir. Baslangiçta 9.3 olan agri skoru 1. ayda 6.9; 4. ayda 4.8; 1. yil sonunda 3.6 olarak degerlendirilmistir. Ozonun bölgesel enjeksiyonlarinin bu kadar etkili oldugu literatürde de yer almaktadir. Ancak bu tedavilerin uygulanabilmesi için mutlaka ozon tedavisi yapilan bir klinik ya da hastaneye gitmek gerekmektedir. Waist hernia and neck hernia are among the most common health problems. In our study, 66 8 sessions of ozone and 2 sessions of prp applications were applied to the patient diagnosed with lumbar hernia. pain according to VAS scoring 1 month after 4 months and 1 year after injections score is checked. The pain score, which was 9.3 at the beginning, was 6.9 at 1 month; 4.8 at 4 months; 1 year It was evaluated as 3.6 at the end. This is how local injections of ozone It is also mentioned in the literature that it is effective. However, for these treatments it is absolutely necessary to go to a clinic or hospital where ozone therapy is performed.
Ozonlanmis yag veya ozonidlerin sudaki solüsyonlari bölgesel uygulamalardaki dozlari burada da geçerlidir. Bölge büyüklügüne göre degismekle birlikte 2 - 4 mg ozonlanmis yag veya ozonidin sudaki çözeltisi paravertebral kaslara ve subkutan dokuya enjekte edilerek antiinflamatuar ve analjezik etkilerden yararlanilabilir. Bununla beraber doku oksijenlenmesi kas spazminin çözülmesi ve fitik bölgesinde kanlanmanin artmasiyla fitigin küçülmesi uzun etkili bir tedavi saglamaktadir. Doses of ozonated oil or ozonide solutions in water in local applications applies here too. Depending on the size of the region, 2 - 4 mg ozonated An aqueous solution of oil or ozonide is injected into the paravertebral muscles and subcutaneous tissue. It can be used for its anti-inflammatory and analgesic effects. However, texture oxygenation, resolution of muscle spasm and increased blood supply in the hernia area. The shrinkage of the hernia provides a long-acting treatment.
Kirik kaynamasinin hizlandirilmasi amaciyla literatürde D vitamini bölgesel enjeksiyonlari denenmis çalismalardir. Ozonlanmis yag veya ozonidlerin sudaki solüsyonlari bölgesel oksijenlenmeyi arttirmaktadir. Bu nedenle kirik hematomu içine ve çevresine ozonlanmis yag veya ozonid enjeksiyonu kirik kaynamasini arttirici etki saglamaktadir. D vitamini, kalsiyum vb. ile kombine kullanimi kaynamayi hizlandirmaktadir. In order to accelerate fracture union, vitamin D has been reported locally in the literature. injections are tried studies. Ozonated oil or ozonides in water solutions increase regional oxygenation. Therefore, into the fracture hematoma Injection of ozonized oil or ozonide to the surrounding area has an effect on increasing the union of the fracture. it provides. Vitamin D, calcium etc. combined use with speeds up.
Yara tedavisinde ozon uygulamasi en etkili yöntemlerden biridir. Yara tedavileri genellikle basarilamamakta ve uzuv kayiplari yasanmaktadir. Ozonun hem bölgesel olarak torba ile yara bölgesine verilmesi hem de bölgesel enjeksiyon ile major tedavi bilinen ozon tedavi yöntemleridir. Ancak ozon tedavi çok yayginlastirilamadigi ve ozon cihazi gerektirdigi için sinirli kullanima sahiptir. Ozonlanmis yag veya ozonidlerin sudaki solüsyonlarinin bölgesel enjeksiyonu ve yogun dozdaki yaglarin birlikte kullanimi yara tedavisinde etkili olmaktadir. Bölgesel enjeksiyonla yara yerine 4 - 5 mg ozonlanmis yag veya ozonidlerin sudaki solüsyonu ve 160 mg ozonlanmis yag veya ozonidin yüzeysel kullanimi sayesinde yara tedavisinde etkin bir rol oynamaktadir. Ozone application is one of the most effective methods in wound treatment. wound treatments it is usually not successful and loss of limb is experienced. Ozone is locally As a major treatment, it is given to the wound area with a bag as well as regional injection. known ozone treatment methods. However, ozone therapy is not widely used and ozone It has limited use because it requires the device. Ozonated oil or ozonides regional injection of solutions in water and intensive doses of oils together Its use is effective in wound treatment. 4-5 mg into the wound by regional injection ozonized oil or a solution of ozonides in water and 160 mg of ozonized oil or Thanks to the superficial use of ozonide, it plays an active role in wound treatment.
Bulus konusu solüsyonlar yara tedavisinde gümüs nano patiküller ile birlikte kullanilabilmektedir. The solutions of the invention are combined with silver nanoparticles in wound treatment. can be used.
Plantar fasciitis, tenisçi dirsegi, tendinitler, bölgesel agrilarin giderilmesinde ozon tedavisi etkili rol oynamaktadir. Ozonlanmis yag veya ozonidlerin sudaki solüsyonlarinin 1 - 2 mg bölgeye uygulanmasi etkili bir tedavi yöntemidir. Ozone in the relief of plantar fasciitis, tennis elbow, tendinitis, regional pain treatment plays an important role. Ozonated oil or ozonides in water Applying 1 - 2 mg of solutions to the area is an effective treatment method.
Uroloiide Ozonlanmis Yag iceren Solüsyonlarinin Kullanimi Sonda uygulamalarinda kullanilan chlorhexidine ve Iidocaine içerikli lubrikatörler içerdigi dezenfektan etki sayesinde sondaya bakteri girisini engellemek amaciyla kullanilmaktadir. Ozonlanmis yag veya ozonidlerin sudaki solüsyonlari bu is için hem nontoksik hem de yag içeriginden dolayi gerçek bir Iubrikant olarak kullanilmaktadir. Use of Solutions Containing Ozonated Oil in Uroloi Lubricants containing chlorhexidine and Iidocaine used in catheter applications Thanks to the disinfectant effect it contains, it is used to prevent bacteria from entering the probe. is used. Solutions of ozonized oil or ozonides in water are both suitable for this work. It is used as a real lubricant due to its non-toxic and oil content.
Lokal anestezikle birlikte uygulandiginda yagdaki ozon saliniminin uzun süreli olmasi ve lokal anestezik saliniminda daha uzun süreli etkisi olmasi sayesinde çok etkili bir edilmelidir. Prolonged release of ozone in oil when applied with local anesthetic and a longer lasting effect on local anesthetic release. should be done.
Sistit ve 'üretrit tedavilerinde hatta üreterin kateterle yapilan uygulamalarda antiinflamatuar, analjezik, antibakteriyel etkili ozonlanmis yag veya ozonid solüsyonlarinin kullanimi bu bölgedeki doku iyilesmesini çok olumlu etkilemektedir. In cystitis and urethritis treatments, even in the applications made with a ureteral catheter ozonized oil or ozonide with anti-inflammatory, analgesic, antibacterial effect The use of solutions has a very positive effect on tissue healing in this area.
Sistit tedavisinde sonda ile mesane içine ozonlanmis yag veya ozonid solüsyonlarinin uygulamasi her gün yapilabilir. Bol sivi alimi önerilmektedir. Mesane içi ve üretranin ozonid solüsyonu ile temasi antibakteriyel, antiinflamatuar etkiyle iyilesmeyi hizlandirmaktadir. Antibiyotikle birlikte ya da sadece ozonlanmis yag veya ozonid solüsyonlarinin tek basina kullanilmasi ile tedavi saglanmaktadir. In the treatment of cystitis, ozonized oil or ozonide solutions are injected into the bladder with a catheter. The application can be done every day. Plenty of fluid intake is recommended. Bladder and urethra contact with ozonide solution improves healing with antibacterial, anti-inflammatory effect. speeds up. Ozonated oil or ozonide alone or with antibiotics Treatment is provided by using the solutions alone.
Kadin Hastaliklarinda Ozonlanmis Yag Içeren Solüsyonlarin Kullanilmasi Kadinlarin genital bölge enfeksiyonlari virütik, bakteriyel, mantar enfeksiyonlari olmak ozonlanmis yag veya ozonid kullanimi etkili bir yöntem olabilmektedir. Use of Ozonated Oil-Containing Solutions in Gynecology The genital tract infections of women can be viral, bacterial, fungal infections. The use of ozonized oil or ozonide can be an effective method.
Dezenfeksiyonun kolaylastirilmasi amaciyla tek kullanimlik dezenfektan mendillerin kullanilmasi enfeksiyon ve kötü kokulardan kurtulmak için iyi bir yöntemdir. Disposable disinfectant wipes to facilitate disinfection. Using it is a good method to get rid of infections and bad odors.
Cinsel iliski öncesi ya da sonrasinda enfeksiyonlarin bulasmasini engellemek amaciyla hem yaglayici özelligi olan hem dezenfektan özelligi olan ozonlanmis yag veya ozonid solüsyonlarin tek kullanimlik ambalajlar halinde hazirlanmasi kullanim kolayligi saglamaktadir. Bu ambalajlarin açilarak vagen içine sikilmasi enfeksiyonlardan koruyucu etki saglamaktadir. Bulus konusu solüsyonlar ov'ul formda veya farkli formlarda kullanilabilmektedir. To prevent the transmission of infections before or after sexual intercourse ozonized oil or ozonide, which has both lubricating and disinfectant properties preparation of solutions in single-use packages, ease of use it provides. Opening and squeezing these packages into the vagina can prevent infections. provides a protective effect. The solutions of the invention are in ov'ul form or in different can be used in forms.
Kadin hastaliklarinda, kisirlik tedavisinde hashas yaginin kullanimi yüz yillarca bilinmektedir. Intrauterin yolla ozonlanmis hashas yaginin yikama solüsyonu seklinde kullanilmasi tubalarda ve uterus içindeki antiinflamatuar etkiyle kanallarin açik kalmasini ve otoimmun sisteme ait olumsuz etkileri ortadan kaldiracagi için infertilite (kisirlik) tedavisinde kullanilmasi etkili bir yöntem olabilmektedir. The use of hash oil in gynecological diseases and infertility treatment has been around for hundreds of years. known. In the form of a washing solution of intrauterine ozonized sunflower oil It is used to open the canals with an anti-inflammatory effect in the tubes and uterus. infertility, as it will eliminate the negative effects of the autoimmune system and It can be an effective method in the treatment of (infertility) treatment.
PID (Pelvik inflamatuar hastalik) enfeksiyonlarinin tedavisinde uterosalfingeal yikama yapilmasi çok etkili bir yöntem olusturmaktadir. Yüksek doz antibiyotiklere ragmen geçirilemeyen PID enfeksiyonlarinda hem virüs hem bakteri hem de mantar kökenli enfeksiyonlarin 'üçünde de etkili olmaktadir. Hiçbir yan etkisi olmayan, tam tersine iyilestirici infertiliteyi tedavi edebilen Ozonlanmis yag veya ozonid solüsyonu tek kullanimda bile etkili bir yikama solüsyonu olusturmaktadir. Haftada 2 - 3 kez, agir enfeksiyonlarda her gün uygulanmasi mümkündür. Uterosalphingeal wash in the treatment of PID (Pelvic inflammatory disease) infections It is a very effective method. Despite high doses of antibiotics In intractable PID infections, both viral, bacterial and fungal origins It is effective in all three infections. On the contrary, with no side effects Ozonated oil or ozonide solution, which can treat curative infertility, is the only It creates an effective washing solution even in use. 2-3 times a week, heavy It is possible to apply it every day in infections.
Göz Hastaliklarinda Ozonlanmis Yag iceren Solüsvonlarin Kullanimi Göz enfeksiyonlari ve alerjik g'oz hastaliklarinda ozonlanmis yag veya ozonid seyreltik solüsyonlarinin göz damlasi olarak kullanilmasi hem enfeksiyonu ortadan kaldirmakta hem de antiinflamatuar, analjezik etki saglamaktadir. Alerjik göz hastaliklarinin tedavisinde kullanilmaktadir. Use of Solutions Containing Ozonated Oil in Eye Diseases Ozonated oil or ozonide dilute in eye infections and allergic eye diseases The use of solutions as eye drops both eliminates the infection. It also provides anti-inflammatory and analgesic effects. allergic eye diseases used in the treatment.
Bulus konusu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar göz damlasi veya farkli formlarda kullanilabilmektedir. Solutions containing ozonized oil in nano or micron sizes are the subject of the invention. It can be used as drops or in different forms.
Kulak, Burun, Bogaz Hastaliklarinda Ozonlanmis Yag Içeren Solüsyonlarin Kullanilmasi Dis kulak ve orta kulak enfeksiyonlari ve dermatitlerinde kullanilan damlalar bakteri enfeksiyonunu yok ederken mantar enfeksiyonunun yerlesmesine sebep olmaktadir. Solutions Containing Ozonated Oil in Ear, Nose, Throat Diseases to use Drops used in outer ear and middle ear infections and dermatitis While destroying the infection, it causes the fungal infection to settle.
Ayni zamanda dermatit varsa tedaviye ayrica yeni bir preparat eklenmesi gerekmektedir Ozonlanmis yag veya ozonid solüsyonlarinin kulak damlasi olarak kullanilmasi bu birden fazla tedavi yöntemin ayni anda uygulanmasini saglamaktadir. If there is dermatitis at the same time, adding a new preparation to the treatment It is necessary to use ozonated oil or ozonide solutions as ear drops. The use of this method enables the simultaneous application of more than one treatment method.
Böylece birkaç ürün kullanilarak yapilan tedavi yerine tek ürünle tedavi saglanmaktadir. Thus, treatment with a single product is provided instead of using several products.
Dozlar enfeksiyon yogunluguna göre degistirilebilmektedir. Günde iki kere ozonlanmis yag veya ozonid solüsyonu kullanimi yeterli olabilmektedir. Kronik dermatitlerde tedavi 1 ay gibi uzun sürelere uzatilabilir. Doses can be changed according to the intensity of infection. ozonized twice a day The use of oil or ozonide solution may be sufficient. Treatment in chronic dermatitis It can be extended for longer periods such as 1 month.
Sinüzit enfeksiyonlari bilindigi gibi tedavisi pek mümkün olmayan akut ya da kronik fazda agri ve bogaz akintisi ile seyreden bir hastaliktir. Pek çok antibiyotik tedavisine ragmen iyilestirilememektedir. Çünkü enfeksiyon odagina ulasmak pek mümkün degildir. Gereksiz antibiyotik kullanimina neden olmaktadir. Bulus ile yapilan çalismalarda basin geri yaslanmasi ile ozonlanmis yag veya ozonid solüsyonunun düzenli olarak kullanilmasi sinüs içine ulasarak hem enfeksiyonun giderilmesi hem de antiinflamatuar ve analjezik etki saglamaktadir. Ayni zamanda bagisiklik sisteminin düzenlenmesi sayesinde alerjik rinit sorunlarini ortadan kaldirarak sinüzit sorununu kalici olarak yok etmektedir. Ozonlanmis yag veya ozonid solüsyonu %40 yogunlukta kullanimi ilk 1 - 2 dakika yakici etkisi oldugundan lokal anesteziklerle kombine verilebilir. Dekonjesyan burun damlalari ya da antiinflamatuar burun damlalariyla kombine edilebilirler. Ancak bunlara pek gerek kalmamaktadir. Ilk uygulama bile tedavide çok etkin rol oynamaktadir. Ancak 1 ay düzenli, günde 1 kez kullanimi ve uygulama sonrasi 15 dakika basin geride tutulmasi ile solüsyonun sinüsler içine girmesinin beklenmesi Önemlidir. Her gün yapilan uygulama sayesinde sinüslerin içi tamamen temizlenmektedir. Ayni zamanda alerjik rinit içinde etkili olacagi için burun kanallarinin açilmasini saglamaktadir. Idame tedaviler burun mukozasinin yumusak tutulmasi anti allerjik, antiinflamatuar etkiler için hazirlanmis ozonlanmis yag veya ozonid içeren burun spreylerinin günde 2 - 3 kez kullanimi burun mukozasini rahatlatarak enfeksiyonlarin olusmasini engellemektedir. Sinusitis infections are acute or chronic, which, as is known, is unlikely to be cured. It is a disease that progresses with pain and throat discharge in the first phase. Many antibiotic treatments however it cannot be improved. Because it is not possible to reach the focus of infection. is not. It causes unnecessary use of antibiotics. made with the invention In studies with the aging of the head, ozonized oil or ozonide solution Its regular use can reach the sinus and both eliminate the infection and It provides anti-inflammatory and analgesic effects. At the same time, the immune system By eliminating allergic rhinitis problems, it solves sinusitis problem. permanently destroying it. Ozonated oil or ozonide solution at 40% concentration It is combined with local anesthetics as it has a burning effect for the first 1 - 2 minutes of use. can be given. With decongestant nasal drops or anti-inflammatory nasal drops they can be combined. However, they are hardly needed. Even the first application plays a very active role in the treatment. However, it should be used regularly for 1 month, once a day and After the application, the solution is entered into the sinuses by keeping the pressure back for 15 minutes. It is important to wait. Thanks to the daily application, the inside of the sinuses is completely cleaned. At the same time, it will be effective in allergic rhinitis. It allows the channels to open. Maintenance treatments of the soft nasal mucosa ozonized oil prepared for anti-allergic, anti-inflammatory effects or The use of ozonide-containing nasal sprays 2-3 times a day will reduce the nasal mucosa. It relieves and prevents the occurrence of infections.
Grip nedeniyle burunda olusan kasintili enfeksiyon tablosunu da ortadan kaldirmaktadir. Yag içerigi sayesinde burun içindeki kabuklanmayi azaltmaktadir. Uzun süreli kullaniminda sakinca yoktur. It also eliminates the itchy infection picture that occurs in the nose due to the flu. removes. Thanks to its oil content, it reduces crusting in the nose. Long there is no calm in its long-term use.
Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar kulak, burun, bogaz hastaliklarinda damla, sprey veya farkli formlarda kullanilabilmektedir. Ayni zamanda uygun maddeler ile kombine edilebilmektedir. Solutions containing ozonized oil in nano or micron sizes can be applied to the ear, nose, throat. It can be used as drops, spray or in different forms in diseases. At the same time It can be combined with suitable substances.
Dis Tedavisinde Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Stomatit, gingivit gibi agiz enfeksiyonlarinda dis etine sürülmesi ya da dis macunu olarak kullanilmasi etkili bir tedavi yöntemidir. Use of Ozonated Oil-Containing Solutions in Dental Treatment It is applied to the gums or toothpaste in mouth infections such as stomatitis, gingivitis. It is an effective treatment method.
Dis çürüklerinin içine ozonlanmis yag veya ozonid solüsyonu %40 gibi dozlarda her gün yapilan uygulama ile kisa sürede çürük kavitesini tedavi ederek enfeksiyonu ortadan kaldirmaktadir. Ozonized oil or ozonide solution into dental caries in doses such as 40% The infection is treated by treating the caries cavity in a short time with daily application. it eliminates.
Dis çekimi ve tedavilerinde lokal anesteziklerle ozonlanmis yag veya ozonid solüsyonu karisiminin enjekte edilmesi bölgesel oksijenlenmeyi arttirarak enfeksiyonu ortadan kaldirmakta ve yara iyilesmesini hizlandirmaktadir. Dis apsesi tedavisinde de apse bölgesine enjekte edilen ozonlanmis yag veya ozonid solüsyonu enfeksiyonu önlemektedir. Dis çekimi sonrasi ve alveolit tedavisinde dis kavitesine ozonlanmis yag veya ozonid solüsyonu lokal olarak sürülmesi enfeksiyonu önlemektedir. Oil or ozonide solution ozonated with local anesthetics in tooth extraction and treatment Injecting the mixture will increase local oxygenation and eliminate the infection. and accelerates wound healing. Abscess in the treatment of tooth abscess Infection with ozonized oil or ozonide solution injected into the area prevents. Ozonated oil into the dental cavity after tooth extraction and in the treatment of alveolitis or local application of ozonide solution prevents infection.
Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar gargara, dis macunu katkisi gibi farkli formlarda agiz bakim ürünlerinde de kullanilabilmektedir. Solutions containing ozonized oil in nano or micron sizes, mouthwash, toothpaste It can also be used in oral care products in different forms such as additives.
Sindirim Sisteminde Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Bogaz enfeksiyonlarinda yüzeysel enfeksiyonu Önlemek amaciyla bogaz pastilleri ile olusturulan ozonlu ürünler agiz ve bogaz antiseptigi olarak kullanilmaktadir. Use of Solutions Containing Ozonated Oil in the Digestive System With throat lozenges to prevent superficial infection in throat infections The ozonized products created are used as mouth and throat antiseptics.
Ozonlanmis yag veya ozonid pastil içine antiseptikler ve tatlandiricilar eklenerek tadi ve etkisi degistirilebilmektedir. Pastiller günde 3 - 5 kez kullanilabilir. Antibiyotik içermedigi için toksik madde içermeyen ayni zamanda 'özofagus hastaliklari içinde kullanilabilecek güvenli bir üründür. %5 - 10 ozonlanmis yag veya ozonid dozlari içeren pastiller tedavi için uygundur. It can be tasted by adding antiseptics and sweeteners into ozonized oil or ozonide lozenge. and its effect can be changed. Lozenges can be used 3-5 times a day. Antibiotic It does not contain toxic substances because it does not contain 'esophageal diseases' It is a safe product to use. 5-10% ozonated oil or ozonide doses containing lozenges are suitable for treatment.
Seyreltik ozonlanmis yag veya ozonid solüsyonlari içeceklerin içine karistirmak amaciyla tek kullanimlik ambalajlar halinde hazirlanarak meyve sularina ya da diger içeceklere karistirilabilir. Bu amaçla ozonlanmis yag veya ozonidli içecekler olusturulabilmektedir. Mixing dilute ozonized oil or ozonide solutions into beverages It is prepared in single-use packages for the purpose of adding fruit juices or other can be mixed into drinks. For this purpose, ozonized oil or ozonated beverages can be created.
Mide hastaliklarinin tedavisinde, özellikle helicobacter pylori eradikasyonunda midede çözünen ozonlanmis yag veya ozonid solüsyonlari günde 1 - 2 kere kullanilmasi etkili bir yöntemdir. Helicobacter pylori eradikasyonunda en az 10 günlük devamli kullanim gerekmektedir. In the treatment of stomach diseases, especially in the eradication of Helicobacter pylori It is effective to use dissolved ozonized oil or ozonide solutions 1-2 times a day. is a method. At least 10 days of continuous use in the eradication of Helicobacter pylori required.
Ozonun bagirsaklardan emilimini saglamak, sistemik olarak kana geçmesiyle kandaki oksijenlenmeyi arttirdigi bilinmektedir. Ozellikle enjekte edilebilen yaglarin bitkisel olanlariyla yapilan bagirsakta eriyen kapsüller kullanilmaktadir. 1 gr yag ile 160 mg kadar ozon tasinmaktadir. Bu dozlardaki bitkisel ozonlu kapsüller sistemik dolasimda etkili ve doku zarari olmayan ozon tedavi yöntemi olusturmaktadir. Genellikle 50 mg ozon içeren ozonlanmis yag veya ozonid kapsülleri kullanilmaktadir. Günde 1 - 2 kapsül kullanimi uygundur. Ensuring the absorption of ozone from the intestines, systemically passing into the blood, It is known to increase oxygenation. In particular, herbal injectable oils Intestinal soluble capsules made with the ones used are used. 160 mg with 1 g fat ozone is transported. Herbal ozone capsules at these doses are in the systemic circulation. It creates an effective and tissue-free ozone treatment method. Usually 50mg ozonized oil or ozonide capsules containing ozone are used. 1 - 2 per day It is convenient to use capsules.
Kalin bagirsak enfeksiyonlarinin, kolitis ülseroza, chron hastaligi gibi otoimmun kökenli hastaliklarin tedavisinde kullanilmak üzere hazirlanmis ozonlanmis yag veya ozonid fitiller 2 gr yag içinde 320 mg ozon yagi içermektedir. Bu fitillerin günde 1 - 2 kere uygulanmasi bagirsak enfeksiyonlarini azaltarak bagirsak oksijenlenmesini arttirmaktadir. Bagisiklik sisteminin düzenlenmesini ve otoimmun bagirsak hastaliklarinin düzeltilmesini saglamaktadir. Ayni zamanda ozonun bagirsaklardan kan dolasimina oksijen geçisini saglamakta ve sistemik etkiler olusturmaktadir. Autoimmune origin of colonic infections such as colitis ulcerosa, chron's disease Ozonated oil or ozonide prepared for use in the treatment of diseases The suppositories contain 320 mg of ozone oil in 2 g of oil. These suppositories are used 1-2 times a day. Its application improves intestinal oxygenation by reducing intestinal infections. is increasing. regulation of the immune system and autoimmune gut it cures the diseases. At the same time, ozone is removed from the blood from the intestines. It ensures the passage of oxygen into the circulation and creates systemic effects.
Major terapiye alternatif etkiler saglamaktadir. Ayni zamanda hemoroid, rektal fistül ve fissürlerin tedavisinde bu fitillerin kullanilmasi etkili olmaktadir. Kantaron otuyla yapilmis ozon yaginin hemoroid tedavisindeki etkinligi bilinmektedir. Nano veya mikron boyutlarda ozonlanmis kantaron yagi içeren solüsyonlar fitil veya farkli formlarda hemoroid tedavisinde kullanilabilmektedir. Bu yaglarin ozonlanmasi sonucu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlardan olusturulan fitiller hemoroid, fistül ve fissürlerin tedavisinde etkili olmaktadir. It provides alternative effects to major therapy. At the same time, hemorrhoids, rectal fistula and The use of these suppositories is effective in the treatment of fissures. with St. John's Wort The effectiveness of the made ozone oil in the treatment of hemorrhoids is known. nano or micron Solutions containing ozonized centaury oil in different sizes can be used as suppositories or in different forms. It can be used in the treatment of hemorrhoids. As a result of ozonation of these oils, nano or Suppositories formed from solutions containing ozonized oil in micron sizes, hemorrhoids, It is effective in the treatment of fistulas and fissures.
Sigmoid kolon enfeksiyonlarinda rektal Iavman uygulamasi yapmak amaciyla olusturulan ozonlanmis yag veya ozonid solüsyonlari tek kullanimlik halde enfeksiyonun ortadan kalkmasini saglarken ayni zamanda sistemik dolasima oksijen geçisini saglamaktadir. Ozellikle yogun bakimlarda beslenme bozuklugu ve kabizlik sorunu olan hastalarda tek kullanimlik ozonlanmis yag veya ozonid solüsyonuyla olusturulan rektal yikama uygulamalari tedavide etkili bir yöntemdir. For rectal application in sigmoid colon infections The ozonized oil or ozonide solutions created are in a single use form. while ensuring the disappearance of the infection, at the same time, oxygen is added to the systemic circulation. makes the transition. Malnutrition and constipation, especially in intensive care with single-use ozonized oil or ozonide solution in patients with The rectal washing applications created are an effective method in treatment.
Peritonitlerde intraperitoneal ozonlanmis yag veya ozonid solüsyonlari enjeksiyonu enfeksiyon tedavisinde etkili bir yöntem olusturmaktadir. Ozonlanmis yag veya ozonid solüsyonu %2 olan 20 mlrlik (cc) enjeksiyonun periton içine günlük uygulanmasi hem enfeksiyonu yok etmek hem de doku rejenerasyonunu olusturmada kullanilmaktadir. Intraperitoneal injection of ozonized oil or ozonide solutions in peritonitis It is an effective method in the treatment of infection. Ozonated oil or ozonide Daily administration of 20 ml (cc) injection with a 2% solution into the peritoneum both It is used both to destroy the infection and to create tissue regeneration.
Bulus konusu nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar farkli pH araliklarinda çözünen kapsül formlarda, fitil formunda veya farkli formlarda ve uygun maddeler ile kombine edilerek üretilebilmektedir. Solutions containing ozonized oil in nano or micron sizes, which are the subject of the invention, are different. It is available in capsule form, suppository form or in different forms and dissolves in pH ranges. It can be produced by combining with suitable materials.
Damar Hastaliklarinda Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Arterlerdeki aterom plaklarinin açilmasi için kullanilan streptokinazin akut fazda damardaki trombüs plagini parçaladigi bilinmektedir. Kolesterolün ozonlanmasi sonucu olusturulan ozonlanmis yag içeren solüsyonlarin arterial yolla verilmesi sonucu aterom plagina yapisan kolesterol üzerindeki ozon sayesinde aterom plagini parçalanarak damarin açilmasini saglamaktadir. K vitamini veya diger uygun etken maddeler ile birlikte verilmesi etkiyi arttirmaktadir. Use of Ozonated Oil-Containing Solutions in Vascular Diseases Streptokinazine, which is used to open atheroma plaques in the arteries, is used in the acute phase. It is known to break up the thrombus plaque in the vein. As a result of ozonation of cholesterol Atheroma as a result of arterial administration of ozonized oil containing solutions created Thanks to the ozone on the cholesterol adhering to the plaque, the atheroma plaque is broken down. It allows the vein to open. with vitamin K or other suitable active ingredients Concomitant administration increases the effect.
Bulusun tercih edilen bir uygulamasinda, kolesterol, trigliserid, fosfolipid gibi yaglarin yüksek ozonlanmasi, K vitaminiyle kombine arterial damar tikanikliginda intra arterial verilmesi damar cidarina yapisan ozonlu yag ürünlerinin antioksidan etkisi ile damarin açilmasi mümkündür. Kolesterolün ozonlanmasi ile elde edilen solüsyonlarin arterial enjeksiyonu aterom plagina yapisarak aterom plagini çözmektedir. In a preferred embodiment of the invention, fats such as cholesterol, triglycerides, phospholipids high ozonation, combined with vitamin K in arterial occlusion, intra-arterial administration of the vein with the antioxidant effect of ozonated oil products adhering to the vein wall. possible to open. Arterial analysis of solutions obtained by ozonation of cholesterol. injection dissolves the atheroma plaque by adhering to the atheroma plaque.
Parenteral dolasima ozon verilmesi alveollerdeki surfactani parçaladigi bilinmektedir. It is known that the administration of ozone to the parenteral circulation breaks down the surfactant in the alveoli.
Soya yaginin 100 - 150 mikrometre partiküllerinin beslenme solüsyonlarinda kullanimi yaglarin damar içi kullanimini saglamaktadir. Ayni sekilde ozonlanmis soya yagi ile olusturulan ozonlanmis yag içeren solüsyonun ultrasonik parçalama yöntemiyle tercihen 50 nanometreye kadar küçük boyutlardaki ozonlanmis yag veya ozonidlerden olusmasi parenteral solüsyonlarda yavas verilmesi ozonun akcigere ulasmadan kanda parçalanarak serbest oksijene dönmesi sonucu zararsiz bir ajan olusturmaktadir. Örnegin; 1 graminda 100 mg ozon içeren ozon yaginin seyreltilmis %1'Iik solüsyonlarinin 500 mI'Iik serum halinde 6 - 8 saatte verilmesi etkili bir parenteral solüsyon olusturmaktadir. Kalp sagligi ve koronerlerin oksijenlenmesini arttiracagi için kalp hastaliklarinda kullanimi etkili olabilmektedir. The use of 100 - 150 micrometer particles of soybean oil in nutritional solutions It provides intravenous use of oils. Likewise with ozonized soybean oil by ultrasonic fractionation of the ozonized oil-containing solution created preferably from ozonized oil or ozonides in small sizes up to 50 nanometers slow release of ozone in parenteral solutions before it reaches the lungs As a result of decomposition to free oxygen, it forms a harmless agent. For example; Diluted 1% of ozone oil containing 100 mg of ozone per gram Solutions of 500 ml of serum in 6 - 8 hours is an effective parenteral solution. forms a solution. Because it will increase heart health and coronary oxygenation Its use in heart diseases can be effective.
Deri Hastaliklarinda Ozonlanmis Yag [ceren Solüsyonlarin Kullanimi Ozonun deri hastaliklarinda ve kozmetikte ozon yagi ve ozonlu su olarak kullanimi yaygindir. Yaglarin ozonlanmasi sonucu ozonlanma miktarlarina göre olusan degisik dozlardaki ozon yaglari halen kullanilmaktadir. Bulus konusu ozonlanmis yag içeren solüsyonlarinin diger yogun ozonlu yaglara göre 1 nanometreden 400 mikrona kadar degisen aralikta ozonlanmis yag içermesi nedeniyle deriden emilimi çok daha hizli olan preparatlar olusturulmaktadir. Bununla birlikte A, D, E, K vitaminleriyle birlikte nano veya mikron boyutlarda partikül haline getirilerek kullanilabilmekte ve onlarinda deriden emilimini arttirmaktadir. Nano veya mikron boyuttaki partiküller sayesinde pek çok maddenin deriden emilimini kolaylastirmaktadir. Ozonated Oil in Skin Diseases [Use of Ceren Solutions Use of ozone in skin diseases and cosmetics as ozone oil and ozonated water it is common. As a result of the ozonation of oils, the differences that occur according to the amount of ozonation doses of ozone oils are still used. The subject of the invention contains ozonized oil. solutions from 1 nanometer to 400 microns compared to other highly ozonated oils. It has a much faster absorption from the skin due to the fact that it contains ozonized oil in a varying range. preparations are made. Along with vitamins A, D, E, K, nano It can be used by making particles in micron or micron sizes and they are also extracted from the skin. increases absorption. Thanks to nano or micron size particles, many It facilitates the absorption of the substance through the skin.
Dermatit, akne, alerjik dermatit, antiaging, kirisiklik önleyici amaçlarla nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar kullanilabilmektedir. For dermatitis, acne, allergic dermatitis, antiaging, anti-wrinkle purposes, nano or Solutions containing ozonized oil in micron sizes can be used.
Mezoterapi amaciyla kullanilmakta olan soya yaglarinin ve alfa Iipoik asidin ozonlanmasi sonucu olusturulan enjekte edilebilir ajanlarin cilt altina verilmesi bulus sayesinde yeni bir yöntemdir. Ozonun Iipolitik özelligi bilinmektedir. Mezoterapi amaciyla ozon gazinin verilmesi etkili bir yag yakici yöntemdir. Alfa Iipoik asit de ayni amaçla kullanilmaktadir. Alfa Iipoik asidin ozonlanmasi ile olusturulan nano veya mikron boyuttaki partiküllerin cilt altina verilmesi ile mezoterapi etkisi artmaktadir. fosfatidil kolin vb. gibi diger mezoterapi ajanlariyla da kombine kullanilabilmektedir. Soybean oils and alpha Iipoic acid used for mesotherapy Subcutaneous administration of injectable agents formed as a result of ozonation thanks to a new method. The Iopolitical property of ozone is known. mesotherapy For the purpose of giving ozone gas, it is an effective fat burning method. Alpha Iipoic acid is the same. used for the purpose. Nano- or The effect of mesotherapy increases with the introduction of micron-sized particles under the skin. phosphatidyl choline etc. It can also be used in combination with other mesotherapy agents such as
Lipolizin sonucu karacigere transfer olan yaglarin ozonlu olmasi sayesinde karacigerde yaglanma etkisi azaltilmaktadir. Haftada 1 - 2 kere uygulanabilir. Thanks to the ozone content of the oils transferred to the liver as a result of lipolysis, lubrication effect is reduced. It can be applied 1-2 times a week.
Saç mezoterapisinde ozonlanmis yag veya ozonid solüsyonlari ile cilt alti uygulamasi bölgesel oksijenlenmeyi arttirarak saç foliküllerinin beslenmesini arttirmaktadir. E vitamini ve minoksidil gibi diger saç mezoterapisi ajanlariyla kombine edilebilmektedir. Subcutaneous application with ozonized oil or ozonide solutions in hair mesotherapy It increases the nutrition of hair follicles by increasing regional oxygenation. TO It can be combined with other hair mesotherapy agents such as vitamin A and minoxidil.
Haftada 1 - 2 kere uygulanabilir. It can be applied 1-2 times a week.
Yüz mezoterapisi amaciyla nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kullanimi cilt altinda oksijenlenmeyi arttirarak kollojen sentezini arttirmaktadir. Dokunun rejenerasyon kabiliyetini arttirarak kirisikliklarin olusumunu azaltmaktadir. Containing ozonized oil in nano or micron sizes for facial mesotherapy The use of solutions increases the oxygenation under the skin and increases the collagen synthesis. is increasing. It prevents the formation of wrinkles by increasing the regeneration ability of the tissue. decreases.
Nano veya mikron boyutlarda ozonlanmis silikon yagini içeren solüsyonlar ve diger ozonlanmis yag içeren solüsyonlar cilt mezoterapisi amaciyla kullanilmaktadir. Bulus sayesinde serbest radikallerin oksitlenmesi ile cilt alti dokularda biriken toksik maddelerin ortamdan uzaklasmasi sayesinde leke olusumunu azaltilmaktadir. Cilt aIti dokulara ozon gazi enjeksiyonunun lekeleri azalttigi bilinmektedir. Ozonlanmis yag içeren solüsyonlarin haftada 1 - 2 kez cilt alti dokulara enjeksiyonu tedavide etkili bir yöntem olusturmaktadir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar E vitamini, A vitamini, C vitamini, hyaluronik asit gibi enjekte edilebilen diger ürünlerle kombine edilebilir. Gözalti morluk tedavisinde K vitaminiyle, C vitaminiyle ve hyaluronik asitle kombine kullanimi etkili bir yöntem olusturmaktadir. Solutions containing ozonized silicon oil in nano or micron sizes and other Solutions containing ozonized oil are used for skin mesotherapy. Meet toxic substances accumulated in subcutaneous tissues by oxidation of free radicals. Thanks to the removal of the substances from the environment, the formation of stains is reduced. skin rash Injection of ozone gas into tissues is known to reduce blemishes. Ozonated oil Injection of solutions containing subcutaneous tissue 1-2 times a week is an effective treatment in the treatment. form method. Containing ozonized oil in nano or micron sizes solutions such as vitamin E, vitamin A, vitamin C, hyaluronic acid Can be combined with other products. With vitamin K, C in the treatment of under-eye bruises It is an effective method when used in combination with vitamin D and hyaluronic acid.
Sampuanlarin içeriklerinde ozonlanmis yag içeren solüsyonlarinin kullanilmasi cildin daha saglikli olmasini saglamakta ve saç dökülmelerini önlemektedir. Using solutions containing ozonized oil in the contents of shampoos It makes it healthier and prevents hair loss.
Kanser Tedavisinde Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Kanser hücrelerinin oksijen ihtiyacinin arttigi ve çevre damarlanmasinin arttigi bilinmektedir. Ozonlanmis yag veya ozonid solüsyonlarinin yüksek oksijen içerdigi de bilinmektedir. Buna göre kemoterapik ilaçlarin ozonlanmis yag içeren solüsyonlar ile birlikte kanserli dokuya verilmesi ile nano veya mikron boyutlardaki ozon yaglarinin kanserli hücrelerin içine kolayca ulasmasi spesifik bir kemoterapik tedavi olusturabilmektedir. Bölgesel olarak verilmesi sistemik kemoterapi etkilerini sinirlandirmis olmaktadir. Mesane tümörleri, bagirsak tümörleri, peritoneal tümörler gibi kavite içi tümörlerde kaviteye kemoterapik ajanla karistirilmis ozonlanmis yag içeren solüsyonlar enjekte edilebilmektedir. Use of Ozonated Oil-Containing Solutions in Cancer Treatment Cancer cells have increased oxygen demand and increased peripheral vascularity. known. Ozonated oil or ozonide solutions also contain high oxygen. known. Accordingly, the treatment of chemotherapeutic drugs with solutions containing ozonized oil. together with the administration to cancerous tissue, ozone oils in nano or micron sizes a specific chemotherapy treatment that can easily reach inside cancerous cells can create. Topical administration of systemic chemotherapy it gets angry. Such as bladder tumors, intestinal tumors, peritoneal tumors containing ozonated oil mixed with chemotherapy agent into the cavity in intra-cavity tumors. solutions can be injected.
Ozonlanmis yag solüsyonlari, kanser tedavisinde bölgesel olarak kanserli dokuya ve çevre dokuya yüksek yogunlukta yüksek dozda verilmesi kanser dokusunu hipoksik hale getirmektedir. Karaciger tümörlerinde hepatik arter yoluyla hashas yaginin enjeksiyonunun kullanilmasi etkili bir tedavi olusturmaktadir. Hashas yagi, nano veya mikron boyutlarda ozonlanarak ayni yolla verilerek kanser hücresi içine girisini kolaylastirilir ve etkisi arttirilabilir. Ozonated oil solutions are applied locally to the cancerous tissue and to the cancerous tissue in the treatment of cancer. administration of high-density high-dose to the surrounding tissue causes cancer tissue to be hypoxic. makes it. Hash oil in liver tumors via hepatic artery The use of injection constitutes an effective treatment. Hash oil, nano or It is injected into the cancer cell by ozonizing in micron sizes and giving it in the same way. facilitated and its effect can be increased.
Nano veya mikron boyutlarda ozonlanmis yagi içeren solüsyonlar, kanser önleme ve kemoterapiye ek olarak düzenli enjeksiyonu antioksidan etkiyi arttirmaktadir. Kanser tedavisinde bölgesel ozonlanmis yag veya ozonid solüsyonu enjeksiyonu yüksek dozlarda kanserli dokuyu anoksiye sokabilmektedir. Solutions containing ozonized oil in nano or micron sizes, cancer prevention and In addition to chemotherapy, regular injection increases the antioxidant effect. Cancer regional ozonized oil or ozonide solution injection in the treatment of high In high doses, it can put cancerous tissue into anoxia.
Veterinerlikte Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Hayvan sagligini korumak amaciyla hem bakteri, virüs ve mantarlarin yok edilmesi, hem de saglikli gelisimlerinin arttirilmasi ve üreme kabiliyetlerinin arttirilmasi amaciyla nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar kullanilabilmektedir. Use of Solutions Containing Ozonated Oil in Veterinary Medicine Destroying both bacteria, viruses and fungi in order to protect animal health, as well as to increase their healthy development and increase their reproductive ability. Solutions containing ozonized oil in nano or micron sizes can be used.
Gelisim sürecindeki hayvanlarin enfeksiyondan ölüm nedenlerini azaltmak için ozonlanmis yag içeren solüsyonlarin haftada bir kez kas içi enjeksiyonu hayvan hastaliklarini önlemede etkili bir yöntemdir. Antibiyotik kullanimini azaltarak maliyetlerin düsmesini saglamaktadir. To reduce the causes of death from infection in animals in the developmental period weekly intramuscular injection of solutions containing ozonized oil It is an effective method to prevent diseases. Cost savings by reducing the use of antibiotics makes it fall.
Besi hayvanlarinin içme sularina karistirilmasi ise hem bagirsak bakteri ve parazitlerinin olusumunu engellemekte hem de hayvanlarin daha saglikli olmalarini saglamaktadir. Mixing it into the drinking water of livestock is both intestinal bacteria and It prevents the formation of parasites and also helps animals to be healthier. it provides.
Nano veya mikron boyutta ozonlanmis yag içeren solüsyonlar, veterinerlikte mastit tedavisinde hem fistül içine hem de bölgesel enjeksiyon seklinde kullanilabilmektedir. Solutions containing ozonized oil in nano or micron size, veterinary mastitis It can be used in the treatment of both fistula and regional injection.
Nano veya mikron boyutta ozonlanmis yag içeren solüsyonlar, veterinerlikte vaginal enfeksiyonlarda vagen içine uygulanmasi, agiz ve burun içi enfeksiyonlarda agiz bölgesine uygulanmasi etkili tedavi yöntemleridir. Solutions containing ozonized oil in nano or micron sizes are used in veterinary vaginal applications. application inside the vagina in infections, oral in oral and intranasal infections application to the area is an effective treatment method.
Nano veya mikron boyutta ozonlanmis yag içeren solüsyonlar, veterinerlikte apse tedavisinde apse kavitesine ve çevre dokuya uygulanabilmektedir. Solutions containing ozonized oil in nano or micron size, abscess in veterinary It can be applied to the abscess cavity and surrounding tissue in the treatment.
Nano veya mikron boyutta ozonlanmis yag içeren solüsyonlar, veterinerlikte eklem tedavisinde insanlarda oldugu gibi eklem içi enjeksiyonlar ve bölgesel agri tedavilerinde bölgesel enjeksiyon yoluyla kullanilabilmektedir. Solutions containing ozonized oil in nano or micron size, joint use in veterinary In the treatment of intra-articular injections and regional pain treatments as in humans It can be used by local injection.
Gida Sektöründe Ozonlanmis Yag /ceren Solüsyonlarin Kullanimi Mevcut teknikte, meyve ve sebzelerin daha parlak görünmesini saglamak amaciyla üzerine parafin ve benzeri yaglar sikilmaktadir. Bu tür islemlerin özellikle sindirim sistemi olmak üzere insan sagligi açisindan birçok zarari bulunmaktadir. Bitkisel yaglarin ozonlanmasi sonucu olusturulan nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarinin seyreltik dozlarda ayni amaçla kullanimi meyve sebzelerin raf ömrünü uzatmaktadir. Yag içeriginden dolayi parlak ve saglikli görünmelerini saglamaktadir. Su içeriginden dolayi kurumalarini engellemektedir. ilaveten insan saglini üzerinde yukarda da bahsedilen olumlu etkileri bulunmaktadir. Bulus konusu solüsyonlarla yapilan çalismalarda, nano veya mikron boyutta ozonlanmis yag içeren solüsyonlar sikilmis meyve ve sebzelerin üzerinde ince tabaka bir tabaka olusmaktadir. Use of Ozonated Oil / Ceren Solutions in the Food Industry In the current technique, in order to make fruits and vegetables appear brighter, paraffin and similar oils are sprayed on it. Such processes are particularly It has many harms in terms of human health, especially the system. Vegetable ozonized oil in nano or micron sizes, which is formed as a result of ozonation of oils the use of solutions containing diluted doses for the same purpose prolongs its lifespan. They make them look bright and healthy due to their oil content. it provides. It prevents them from drying out due to its water content. additionally human It has positive effects on health mentioned above. subject of the invention In studies with solutions, nano or micron size ozonized oil containing A thin layer forms on the solution-squeezed fruits and vegetables.
Bu tabaka sayesinde bakteri ve mantarlarin meyve ve sebzeler üzerinde üremesi engellenerek çürüme süreci geciktirilmektedir. Thanks to this layer, bacteria and fungi reproduce on fruits and vegetables. by preventing the decay process.
Bilindigi gibi meyve ve sebzelerin raf ömrünün uzatilmasi ihracatta önemli bir unsurdur. As it is known, extending the shelf life of fruits and vegetables is an important factor in export.
Domatesin tir nakliyatiyla baska bir ülkeye gönderilmesi gümrükte yasanan gecikmeler, soguk hava sistemlerinde bozulma gibi degisik sebeplerle bazen gidecegi yere ulastiginda malin ayipli hale gelmesine ve kabul görmemesine sebep olmaktadir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar, meyve ve sebzelerin ozonlanmis yag veya ozonid tabakasi sayesinde temas ettigi yerdeki zedelenmelerden etkilenmemekte ve bakteri, mantar olusumu önlendigi için çürüme süresi çok daha uzun olmaktadir. Bulusun bir uygulamasinda, içinde 40 gr ozon bulunan 1 litre ozonlanmis yag veya ozonid solüsyonu 100 litre su içine karistirilmaktadir. Karistirma isleminin mikser yardimiyla yapilmasi solüsyonun daha iyi dagilmasini saglamaktadir. Delays in customs when sending tomatoes to another country by truck transportation, Sometimes they go to their destinations for different reasons such as deterioration in cold air systems. when it is reached, it causes the goods to become defective and not accepted. nano solutions containing ozonized oil in micron sizes, fruit and vegetables Thanks to the ozonized oil or ozonide layer, it is protected from the injuries in the contact area. It is not affected and the decay time is much longer as the formation of bacteria and fungi is prevented. it is long. In one embodiment of the invention, 1 liter containing 40 g of ozone The ozonized oil or ozonide solution is mixed into 100 liters of water. To mix up Doing the process with the help of a mixer ensures better distribution of the solution.
Paketleme esnasinda bant üzerinde de spreyleme yapilabilmektedir. Bulus konusu solüsyonlar ile yapilan çalismalarda bir grup meyve ve sebze üzerine tercihen %1'Iik ozonlanmis yag içeren solüsyon sikilmis ve bir grup meyve ve sebze üzerine ozonlanmis yag içeren solüsyon sikilmamistir. Bu meyve ve sebzeler oda isisinda bekletilmistir. 10 gün sonra ozonlanmis yag içeren solüsyon sikilmayan meyve ve sebzelerde burusma ve çürüme kabul edilemez seviyede iken ozonlanmis yag içeren solüsyon sikilmis meyve ve sebzelerin saglikli görüntülerini kaybetmedigi görülmüstür. It is also possible to spray on the band during packaging. subject of the invention In studies with solutions, preferably 1% on a group of fruits and vegetables. The solution containing ozonized oil was squeezed and placed on a group of fruits and vegetables. The solution containing ozonized oil has not been squeezed out. These fruits and vegetables are at room temperature. is pending. After 10 days, the solution containing ozonized oil is not squeezed fruit and While wrinkling and rot in vegetables is unacceptable, it contains ozonized oil. It has been observed that solution-squeezed fruits and vegetables do not lose their healthy appearance.
Yapilan çalismada kullanilan ozonlanmis yag içeren solüsyonun %1'lik orani sinirlayici bir deger degildir. Bu oran arttirilabilir. Eger bu oran arttirilirsa meyve ve sebzelerinde dayanikliligi da dogru orantili olarak artmaktadir. Bitkisel yaglarin ozonlanmasi sonucu elde edilen solüsyonlarin kullanilmasi nedeniyle bu sebze ve meyvelerin yenmesinde hiçbir sakinca bulunmamaktadir. Tam tersine bu sekilde yenmeleri ile ozonlu yaglarin sindirim sistemi üzerindeki olumlu etkilerinden faydalanilmaktadir. The rate of 1% of the solution containing ozonized oil used in the study was limiting. it is not worth it. This rate can be increased. If this rate is increased, fruits and vegetables its durability also increases proportionally. As a result of ozonation of vegetable oils In the consumption of these vegetables and fruits due to the use of the solutions obtained there is no calmness. On the contrary, ozonated oils are consumed in this way. benefit from its positive effects on the digestive system.
Ayni sekilde etlerin ozon gazindan geçirilerek paketlenmesi, etlerin raf ömrünü iki kat arttirdigi bilinmektedir. Bitkisel kökenli yaglarin ozonlanmasiyla olusturulan nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin beyaz etlerin ve kirmizi etlerin paketlenmesi esnasinda seyreltik dozlarda ince tabaka halinde sikilmasi etlerin hem canli görünmesini hem de içindeki su içerigiyle kurumasini önleyici etki göstermektedir. Likewise, packaging the meats by passing through ozone gas doubles the shelf life of the meat. known to increase. The nano or of solutions containing ozonized oil in micron sizes, of white meats and red meats. During packaging, squeezing in thin layers in dilute doses ensures that the meats are both It has a lively appearance and prevents drying with its water content.
Ayni zamanda bakteri, virüs ve mantar kontaminasyonlarini önlemektedir. Böylece etlerin raf ömrünü uzatmaktadir. Bu besinlerin yenmesinde hiçbir sakinca bulunmamaktadir. Bilindigi gibi ozonlanmis yaglarin veya ozonidlerin yutuldugunda sindirim sistemini iyilestirici etkileri bulunmaktadir. Paketlenmis yiyeceklerin ve içeceklerin bozulmasini önlemek amaciyla stabilizatör madde olarak nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin kullanilmasi hem zararsiz hem de sindirim sistemi ve genel vücut sagligi için yararli bir katki maddesi olmasini saglamaktadir. It also prevents bacterial, viral and fungal contaminations. Like this prolongs the shelf life of meat. There is no calmness in eating these foods. does not exist. As it is known, when ozonated oils or ozonides are swallowed It has effects on the digestive system. packaged food and nano or micron as a stabilizer to prevent beverages from spoiling The use of solutions containing ozonized oil in large sizes is both harmless and safe. to be a useful additive for the digestive system and general body health. it provides.
Tavuk Yetistiriciliginde Ozonlanmis Yag Içeren Solüsyonlarin Kullanilmasi Ozon haplarinin kullaniminin insan sagligina yararlari bilinmekte ve uzun yillardir kullanilmaktadir. Ozellikle mide ve barsak enfeksiyonlarinin tedavisinde etkisi çok fazladir. Ayni zamanda parazit ve mantar enfeksiyonunda da etkindir. Ayni zamanda saglik durumunu iyilestirir ve vücuda oksijen saglar. Ayni durum hayvan sagligi içinde geçerlidir. Ozellikle tavuk çiftliklerinde sikisik halde yasayan tavuklarin enfeksiyonlarinin birbirine geçirmesi çok sik rastlanan bir durumdur ve büyük salginlara neden olmaktadir. Bu da toplu halde ölümlere neden olmaktadir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin tavuklarin içtigi sulara katilmasi hem enfeksiyonlarin önüne geçmek hem daha saglikli tavuklar yetistirmeyi saglamaktadir. Using Solutions Containing Ozonated Oil in Chicken Breeding The benefits of the use of ozone pills on human health are known and have been for many years. is used. It is especially effective in the treatment of stomach and intestinal infections. is too much. It is also effective in parasitic and fungal infections. At the same time It improves health status and provides oxygen to the body. The same is true for animal health. valid. Especially in chicken farms, the hens living in congested infections are very common and can lead to major outbreaks. causes. This causes mass deaths. nano or micron The addition of solutions containing ozonized oil to the waters of chickens Preventing infections allows raising healthier chickens.
Tavuklarin içme sularina katilan nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin hesabi, günlük insanlara verilen doz/kilo hesabina göre yapilabilmektedir. Containing ozonized oil in nano or micron sizes added to the drinking water of chickens. The calculation of the solutions can be made according to the daily dose/weight calculation given to the people.
Ayni zamanda ortama salinan ozon tavuk çiftligindeki kötü kokularin ortadan kalkmasini saglamakta ve havada uçan bakteri sayisini azaltmaktadir. Ornegin; insanlar için hazirlanmis ozon kapsüllerinde 40 mg ozon bulunmaktadir. Tavuklarin 2 kg oldugunu varsayilarak 1 mg'lik dozun içme suyuna karistirilmasi yeterli olmaktadir. At the same time, the ozone released to the environment eliminates the bad odors in the chicken farm. It helps to lift and reduces the number of bacteria flying in the air. For example; There is 40 mg ozone in ozone capsules prepared for humans. your chickens 2 Assuming that it is kg, it is sufficient to mix a dose of 1 mg into the drinking water.
Bulusun tercih edilen bir uygulamasinda, 1 Iitresinde 40 gr ozon bulunan ozonlanmis olan 1 litre ozonlanmis yag içeren solüsyon, tavuklarin ihtiyaç olan günlük su miktari içine karistirilabilmektedir. Karisimin mikser yardimiyla yapilmasi dengeli dagilmasini saglamaktadir. In a preferred embodiment of the invention, ozonized ozone containing 40 g ozone per 1 liter 1 liter of ozonized oil containing solution, the daily water amount chickens need can be mixed in. Making the mixture with the help of a mixer ensures balanced distribution. it provides.
Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar tavuk yetistiriciliginde kullanilarak tavuklarin daha saglikli yumurta yapmalarini ve bulasici hastaliklardan korunmalarini saglamaktadir. ilaveten tavuk yetistiriciliginde antibiyotik kullanimini azaltilmaktadir. Solutions containing ozonized oil in nano or micron sizes are used in chicken breeding. By using it, chickens make healthier eggs and prevent infectious diseases. ensures their protection. In addition, the use of antibiotics in chicken breeding is being reduced.
Bitki /Iaçlamada Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Ozonlanmis yag içeren solüsyonlarinin seyreltik hale gelmesiyle ve yag içeriginden dolayi uygulandigi yerde uzun süre kalabilmesi nedeniyle bitkilerin ilaçlanmasinda etkili bir yöntem olusturmaktadir. Sebze ve meyvelerin ozonid solüsyonu ile ilaçlanmasi sonucu üzerinde olusturdugu ince tabaka 3 hafta kadar kalmakta ve zararlilarin sebze ve meyve üzerinde olusturdugu gözle görülmez ince deliklerden çürümenin baslamasini engelleyerek kabugu beslemektedir. Hava sartlarina göre bitki üzerinde kalma süresi 2 - 3 hafta kadar oldugu düsünüldügünde sebze ve meyvelerin gelisme döneminde 3 hafta arayla ozonlanmis yag içeren solüsyonlarin uygulamasi bitki sagligina önemli katkilarda bulunabilmektedir. Use of Ozonated Oil-Containing Solutions in Plant / Spraying By diluting the solutions containing ozonated oil and reducing the oil content. It is effective in spraying plants because it can stay for a long time in the place where it is applied. creates a method. Spraying of vegetables and fruits with ozonide solution As a result, the thin layer formed on it stays for up to 3 weeks and the pests and rot from the invisible fine holes on the fruit. It feeds the shell by preventing it from starting. On the plant according to the weather conditions When it is thought that the residence time is about 2 - 3 weeks, the development of vegetables and fruits The application of solutions containing ozonized oil at intervals of 3 weeks during the can make significant contributions to health.
Tarim ilaçlari gibi sagliga zararli olmamasi ve yutulmasinda fayda olmasi nedeniyle hem ilaçlama esnasinda hem de yenmesi halinde bir zarar olusturmamaktadir. Because it is not harmful to health like agricultural pesticides and it is beneficial to swallow It does not cause any harm both during spraying and in case of ingestion.
Ilaçlama esnasinda solunmasi zarar olusturabilir ve gözlerde yanma yapabilir. Bu nedenle ilaçlama sirasinda maske kullanilmalidir. Ancak bir miktar yutulmasinda sakinca bulunmamaktadir. Bulusun tercih edilen bir uygulamasinda 100 litre su içine 1 litre ozonlanmis yag içeren solüsyonunun mikser yardimiyla karistiriarak eklenmesi ve sikilmasi yeterli olmaktadir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar organik tarimda kullanimi uygundur. Inhalation during spraying may cause harm and may cause burning in the eyes. This Therefore, a mask should be used during spraying. However, in swallowing a small amount calmly absent. In a preferred embodiment of the invention, 1 per 100 liters of water adding a liter of ozonized oil-containing solution by mixing with the help of a mixer and squeezing is enough. Containing ozonized oil in nano or micron sizes The solutions are suitable for use in organic farming.
Bitki ilaçlamasi maliyetlidir ve kimyasal atiklarin dogaya yayilmasindan dolayi insan sagligini olumsuz etkilemektedir. Ozonlanmis yag içeren solüsyonlar ile yapilan ilaçlama tamamen dogal, bitkiye zarar vermeyen ve zararli bakteri ve mantarlarin çürük olusturmasini engelleyen bir etki saglamaktadir. Plant spraying is costly and due to the spread of chemical wastes in nature, human negatively affects their health. made with solutions containing ozonated oil. spraying is completely natural, does not harm the plant and harmful bacteria and fungi It has an effect that prevents it from forming.
Süs Bitki Korumada Ozonlanmis Yag Içeren Solüsyonlarin Kullanilmasi Süs bitkilerinin yapraklarinin korunmasi ve daha parlak görünmesi için uygulanmakta olan parafinin yogun bir yag olmasi nedeniyle yaprak üzerinde parlak bir görüntü olustururken yapragin hava almasini önlemektedir. Uzun süre kullanilmasi yaprak üzerinde mantar olusumuna sebep olmaktadir. Using Solutions Containing Ozonated Oil in Ornamental Plant Protection It is applied to protect the leaves of ornamental plants and make them look brighter. A bright image on the leaf due to the fact that paraffin, which is an oil, is dense. It prevents the leaf from getting air while forming. Long-term use leaf causes fungal growth.
Seyreltilmis ozonlanmis yag içeren solüsyonlarin tercihen sprey olarak kullanilmasi yag oraninin düsük olmasi ve oksijen salgilama özelliginden dolayi hem bitkinin ömrünü uzatmakta hem de az miktarda yag içerigi ile yaprak üzerinde ince tabaka olusturarak yapragin daha parlak görünmesini saglamaktadir. Bulusun tercih edilen bir uygulamasinda 10 gün araliklarla spreyleme bitkinin parlak görünmesi için yeterli olmaktadir. Bunun için %1'Iik solüsyonlari kullanmak yeterlidir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar bitki üzerinde mantar ve bakteri olusumunu önlemektedir. Solutions containing diluted ozonized oil should preferably be used as a spray. Due to its low rate and its oxygen-secreting feature, it will both extend the life of the plant. It not only extends it but also creates a thin layer on the leaf with a small amount of oil content. It makes the leaf look brighter. Invent a preferred Spraying at 10-day intervals is sufficient to make the plant look bright. is happening. For this, it is sufficient to use 1% solutions. nano or micron solutions containing ozonized oil in different sizes, fungi and bacteria on the plant prevents its formation.
Süs bitkilerinin korunmasi ve yaprak sagliginin arttirilmasi amaciyla ozonlanmis yag içeren solüsyonlarin bitki yapraklarina ve gövdesine sikilmasi bitki sagligini arttirici etki göstermektedir. Ozonated oil to protect ornamental plants and increase leaf health squeezing the solutions containing it on the leaves and stem of the plant has a plant health-enhancing effect. shows.
Kimya Sektöründe Ozonlanmis Yag Içeren Solüsyonlarin Kullanimi Güçlü bir dezenfektan olan ozonun su dezenfeksiyonu, depo ve hijyenik alanlarin dezenfeksiyonu amaciyla kullanildigi bilinmektedir. Use of Solutions Containing Ozonated Oil in the Chemical Industry Water disinfection of ozone, which is a powerful disinfectant, is used in warehouses and hygienic areas. It is known to be used for disinfection.
Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar, bulasik deterjanlari ve temizlik maddeleriyle karistirilarak hem deterjanin dezenfektan etkisini arttirmakta hem de bulasik deterjanlari ve temizlik maddelerinin deride olusturdugu toksik etkiyi azaltarak kontakt dermatitlerin olusmasini önlemektedir. Solutions containing ozonized oil in nano or micron sizes, dishwashing detergents and by mixing with cleaning agents, it increases the disinfectant effect of the detergent. as well as the toxic effect of dishwashing detergents and cleaning agents on the skin. It reduces the occurrence of contact dermatitis.
Bulusun tercih edilen bir uygulamasinda, deterjanlarin hazirlanmasi esnasinda %3 - 5 oranlarinda ozonlanmis yag içeren solüsyonlarin karistirilmasi hem deterjanin dezenfektan etkisini arttirmakta hem de deterjanlarin cilt üzerindeki olumsuz etkilerine karsi tedavi edici etkiler saglamaktadir. In a preferred embodiment of the invention, 3-5% is used during the preparation of detergents. Mixing solutions containing ozonized oil in ratios of It increases the disinfectant effect as well as the negative effects of detergents on the skin. provides therapeutic effects.
Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar temizlik maddeleri içerigine eklenerek farkli form ve amaçlarla kullanilabilmektedir. Solutions containing ozonized oil in nano or micron sizes cleaning agents It can be used in different forms and purposes by adding it to its content.
Hiivenik Mendillerde Ozonlanmis Yag iceren Solüsyonlarin Kullanimi Hijyen amaciyla kullanilan tek kullanimlik mendiller; çocuk popo mendilleri, el silme mendilleri, genital organ temizligi, yara bakimi, makyaj silme, yüz ve cilt bakimi, sigillerin giderilmesi için olusturulan mendiller gibi gruplara ayrilabilir. Bulus konusu solüsyonlarda ozonun dezenfektan olarak kullanilmasi, doku iyilestirici özelliginin bulunmasi ve yaglarin dokuyu nemli tutmasi nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlarin çok amaçli kullanilmasini saglamaktadir. Bulus konusu solüsyonlar, içinde toksik maddeler barindiran diger ürünlere göre hiçbir yan etki içermemektedir. Aksine doku iyilestirici özellikler içermektedir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar, mendillerde tek basina kullanildiginda tercihen %2 - 5 oranlarinda kullanilabilir. Use of Solutions Containing Ozonated Oil in Hyvenik Wipes Disposable wipes used for hygiene; children's butt wipes, hand wiping wipes, genital organ cleaning, wound care, make-up removal, face and skin care, It can be divided into groups such as wipes created for the removal of warts. subject of the invention the use of ozone as a disinfectant in solutions, tissue healing properties Ozonated in nano or micron sizes It enables the multi-purpose use of solutions containing oil. subject of the invention solutions have no side effects compared to other products containing toxic substances. does not include. On the contrary, it contains tissue healing properties. nano or micron sizes of solutions containing ozonized oil, when used alone in wipes preferably 2 - 5% can be used.
Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar, bebeklerde yag içeriginden dolayi pisik olusumunu önlemektedir. Bu nedenle baska kremlerin kullanilmasina gerek kalmamaktadir. Diger antibakteriyel ajanlarla birlikte kullanilabilmektedir. Solutions containing ozonized oil in nano or micron sizes It prevents the formation of dirt due to its content. That's why other creams there is no need to use it. In combination with other antibacterial agents can be used.
Genital temizlik amaciyla, nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar %10 - 20 gibi yüksek oranlarda kullanilarak mantar ve virüslerin olusumunu engellemektedir. Cinsel iliski öncesi ve sonrasi kullanilmasi temas yoluyla olusan kontaminasyonlari engellemektedir. Ayni zamanda doku iyilesmesini arttirmaktadir. Nano veya mikron boyutlarda ozonlanmis yag içeren solüsyonlar ile birlikte vagen içi solüsyonlarin kullanilmasi da uygundur. For genital cleaning, containing ozonized oil in nano or micron sizes. The solutions are used at high rates such as 10 - 20% to prevent fungi and viruses. prevents its formation. Before and after sexual intercourse, by contact prevents contamination. At the same time, tissue healing is increasing. With solutions containing ozonized oil in nano or micron sizes It is also appropriate to use intravaginal solutions together.
Claims (1)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2018/04452A TR201804452A2 (en) | 2018-03-29 | 2018-03-29 | OZONEED OIL CONTAINING SOLUTIONS |
US17/040,825 US20210007360A1 (en) | 2018-03-29 | 2019-03-29 | Solutions comprising ozonized oil |
PCT/TR2019/050209 WO2019240713A2 (en) | 2018-03-29 | 2019-03-29 | Solutions comprising ozonized oil |
EP19819129.8A EP3775120A4 (en) | 2018-03-29 | 2019-03-29 | Solutions comprising ozonized oil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2018/04452A TR201804452A2 (en) | 2018-03-29 | 2018-03-29 | OZONEED OIL CONTAINING SOLUTIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201804452A2 true TR201804452A2 (en) | 2018-06-21 |
Family
ID=66999412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2018/04452A TR201804452A2 (en) | 2018-03-29 | 2018-03-29 | OZONEED OIL CONTAINING SOLUTIONS |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3775120A4 (en) |
TR (1) | TR201804452A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR2021004032A2 (en) * | 2021-03-01 | 2022-09-21 | Ahmet Uemit Sabanci | LIPOSOMAL OZONE NANOSOLUTIONS |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3504038A (en) * | 1966-06-24 | 1970-03-31 | Us Agriculture | Ozonization of vegetable oils in an improved aqueous medium |
ES2162586B1 (en) * | 1999-11-25 | 2002-07-01 | Moraleda Manuel Gomez | COMPOSITION THAT INCLUDES OZONIZED OILS AND / OR OTHER NATURAL AND / OR SYNTHETIC SYNTHETIC PRODUCTS, AND ITS USE IN PHARMACEUTICAL, COSMETIC, DIETETIC OR FOOD SUPPLEMENT COMPOSITIONS, IN HUMAN AND VETERINARY FIELDS |
RU2322217C2 (en) * | 2006-01-23 | 2008-04-20 | Валерий Викторович Педдер | Ozone/no-ultrasonic therapy method for treating exudative sinusitis cases |
IT1398503B1 (en) * | 2010-02-24 | 2013-03-01 | Alderan S A S Di Alderano Mannozzi & C Ora Alderan S A S Di D Ottavi Adele & C | USE OF TAMPONANT SUBSTANCES TO MAKE THE CURLY HAIR, SMOOTH OR CORRUGATED. |
ITMI20110354A1 (en) * | 2011-03-07 | 2012-09-08 | Neovalis S R L | COMPOSITION BASED ON OZONIZED OIL FOR TOPICAL USE |
CN103430797B (en) * | 2013-08-13 | 2015-08-05 | 陕西省微生物研究所 | A kind of method of preventing and treating cucumber fungal disease |
EP3139738B1 (en) * | 2014-05-07 | 2019-11-27 | Multiossigen S.P.A. | Product for activating defence mechanisms in plants |
CN106560216A (en) * | 2015-09-30 | 2017-04-12 | 高晓峰 | Essential oil for treating gynaecological diseases and preparation method thereof |
IT201600106992A1 (en) * | 2016-10-24 | 2018-04-24 | General Services Spain Italy Sl | Composition comprising microstructures for the controlled release of ozonated oil. |
CN107088185B (en) * | 2017-06-09 | 2020-07-17 | 甘肃新天马制药股份有限公司 | Ozonized oil bicontinuous phase emulsion and preparation method and application thereof |
CN107582472A (en) * | 2017-10-31 | 2018-01-16 | 山东朱氏堂医疗器械有限公司 | A kind of skin care compositions, facial mask liquid, facial mask and preparation method thereof |
IT201800009063A1 (en) * | 2018-10-01 | 2020-04-01 | Project & Communications Ltd | FORMULATION INCLUDING OZONIZED OIL IN THE TREATMENT OF A CANCER |
-
2018
- 2018-03-29 TR TR2018/04452A patent/TR201804452A2/en unknown
-
2019
- 2019-03-29 EP EP19819129.8A patent/EP3775120A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP3775120A4 (en) | 2021-06-02 |
EP3775120A2 (en) | 2021-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019240713A2 (en) | Solutions comprising ozonized oil | |
US9220290B2 (en) | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same | |
JP7242718B2 (en) | Formulations containing pomegranate seed oil, rosa canina fruit oil, and inula viscosa oleoresin or extract | |
US5554361A (en) | Processed product for skin and hair treatment | |
US20230165825A1 (en) | Novel anhydrous compositions comprised of marine oils | |
EP3439676B1 (en) | Fish oil topical composition | |
TR201804452A2 (en) | OZONEED OIL CONTAINING SOLUTIONS | |
WO2013040721A1 (en) | Method and system for producing ozonated natural oils and the application thereof in the treatment of humans, animals and vegetables, and in aquaculture | |
US20240139138A1 (en) | Composition of and method for treating injury and/or skin conditions | |
Vollmer | Healing with DMSO: The Complete Guide to Safe and Natural Treatments for Managing Pain, Inflammation, and Other Chronic Ailments with Dimethyl Sulfoxide | |
WO2004071477A1 (en) | Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use | |
WO2009020398A2 (en) | Skin care product | |
TW201642846A (en) | Carboxymethylcysteine for topical treatment of stretch marks | |
EP2722050A2 (en) | Use of olive oil to prevent and to treat diseases involving an ischemic process | |
US11986508B1 (en) | Nutritional and cosmetic product, system and method for use | |
Branson | 101 Amazing Uses for Coconut Oil: Decrease Wrinkles, Balance Hormones, Clean a Hairbrush, and 98 More! | |
WO2019178658A2 (en) | Healing, moisturizing, humectant and emolient composition for topical administration in intertrigo skin lesions, skin lesions due to urinary and faecal incontinence and other related injuries. | |
Pawar et al. | WOUND HEALING OINTMENT | |
Wilson | Topical Shark Cartilage Subdues Psoriasis Research Review and Preliminary Clinical Results | |
Gresswell et al. | The Bovine Prescriber: Drawn Up for the Use of Veterinary Practitioners and Students |